[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fWKJRWTQbCvMytWzLAiPthTYvNogaiM3-l0gsNEoCFaQ":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":36,"phaseBuckets":87,"rows":94},"Tel-Aviv Sourasky Medical Center",[4],544,false,40,36,110126,16,390,[14,17,20,23,26,29,31,33],{"name":15,"count":16},"Pain",11,{"name":18,"count":19},"Parkinson Disease",10,{"name":21,"count":22},"Parkinson's Disease",9,{"name":24,"count":25},"Obesity",8,{"name":27,"count":28},"Healthy",7,{"name":30,"count":28},"Crohn Disease",{"name":32,"count":28},"Ulcerative Colitis",{"name":34,"count":35},"Asthma",6,[37,42,47,52,57,62,67,72,77,82],{"nctId":38,"briefTitle":39,"date":40,"intervention":41},"NCT05117034","Pre-emptive Intravenous Morphine for Acute Post-craniotomy Pain.","2025-05-01","Morphine",{"nctId":43,"briefTitle":44,"date":45,"intervention":46},"NCT05329636","Auto Fecal Microbial Transplant Post Helicobacter Pylori Antibiotic Therapy","2025-07-01","Fecal Microbial Transplant",{"nctId":48,"briefTitle":49,"date":50,"intervention":51},"NCT06510426","Early Interferon-beta Treatment for West-Nile Virus Infection","2025-07-14","Rebif 44 MCG Per 0.5 ML Prefilled Syringe",{"nctId":53,"briefTitle":54,"date":55,"intervention":56},"NCT06600776","Mealtime or Post-meal Dosing of URLi in Medtronic 780G Hybrid Closed Loop System","2025-09-21","Ultra Rapid Lispro",{"nctId":58,"briefTitle":59,"date":60,"intervention":61},"NCT04790474","Ixazomib-pomalidomide-dexamethasone as Second or Third-line Combination Treatment for Patients With Relapsed and Refractory Multiple Myeloma Previously Treated With Daratumumab, Lenalidomide and Bortezomib","2026-03-01","ixazomib-pomalidomide-dexamethasone",{"nctId":63,"briefTitle":64,"date":65,"intervention":66},"NCT06839144","Inhibiting Beta-adrenergic and COX-2 Signaling During the Perioperative Period to Reduce Ovarian Cancer Progression","2026-08-31","Propranolol",{"nctId":68,"briefTitle":69,"date":70,"intervention":71},"NCT06581458","Home Transcranial Direct-Current Stimulation for Motoric Cognitive Risk Syndrome","2026-09","tDCS",{"nctId":73,"briefTitle":74,"date":75,"intervention":76},"NCT07361224","Investigator Initiated Study to Assess the Safety of Combination of CLS-015 With Anti-CD-19 CAR-T Cells in Patients With Stable\u002FProgressive Large B Cell Lymphoma at Lymphodepletion.","2027-02","rhDNase I",{"nctId":78,"briefTitle":79,"date":80,"intervention":81},"NCT06967194","Early Beta Blocker Administration in STEMI Patients With SCAI B Status","2027-05","Metoprolol",{"nctId":83,"briefTitle":84,"date":85,"intervention":86},"NCT02497820","Finding the Best Dose of Aspirin to Prevent Lynch Syndrome Cancers","2027-09","Aspirin",[88,89,90,91,92,93],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[95,120,141,168,192,218,240,262,280,323,345,405,423,444,469,492,510,545,570,599,617,635,662,686,712,737,767,785,803,821,839,866,892,917,935,963,990,1015,1033,1057,1080,1105,1130,1156,1174,1192,1213,1255,1292,1328,1352,1378,1396,1421,1446,1464,1487,1505,1531,1549,1572,1596,1621,1647,1665,1692,1710,1728,1746,1764,1782,1807,1832,1858,1882,1906,1928,1951,1975,1997,2021,2044,2071,2099,2124,2148,2173,2196,2220,2241,2264,2289,2314,2346,2364,2382,2400,2422,2446,2470,2497,2519,2543,2605,2659,2701,2727,2756,2782,2812,2838,2869,2902,2928,2958,2980,3003,3025,3043,3068,3086,3108,3130,3151,3175,3197,3221,3243,3266,3296,3314,3332,3350,3374,3392,3416,3441,3459,3484,3507,3525,3552,3570,3588,3615,3633,3659,3681,3703,3725,3749,3772,3796,3814,3836,3860,3885,3913,3931,3953,3983,4001,4028,4053,4077,4100,4125,4149,4167,4197,4215,4240,4262,4285,4309,4327,4345,4370,4388,4413,4431,4454,4472,4490],{"intervention":56,"totalTrials":96,"cells":97},1,{"EARLY_PHASE1":98,"PHASE1":101,"PHASE2":103,"PHASE3":105,"PHASE4":107,"NA":118},{"trials":99,"activeCount":100},[],0,{"trials":102,"activeCount":100},[],{"trials":104,"activeCount":100},[],{"trials":106,"activeCount":100},[],{"trials":108,"activeCount":96,"soonestReadout":55},[109],{"nctId":53,"briefTitle":54,"status":110,"phases":111,"primaryCompletion":55,"completion":112,"start":113,"enrollment":114,"conditions":115,"interventions":117},"NOT_YET_RECRUITING",[92],"2025-10-21","2024-10-06",50,[116],"Type 1 Diabetes (T1D)",[56],{"trials":119,"activeCount":100},[],{"intervention":86,"totalTrials":96,"cells":121},{"EARLY_PHASE1":122,"PHASE1":124,"PHASE2":126,"PHASE3":128,"PHASE4":137,"NA":139},{"trials":123,"activeCount":100},[],{"trials":125,"activeCount":100},[],{"trials":127,"activeCount":100},[],{"trials":129,"activeCount":96,"soonestReadout":85},[130],{"nctId":83,"briefTitle":84,"status":110,"phases":131,"primaryCompletion":85,"completion":85,"start":132,"enrollment":133,"conditions":134,"interventions":136},[91],"2016-09",1800,[135],"Lynch Syndrome I (Site-specific Colonic Cancer)",[86],{"trials":138,"activeCount":100},[],{"trials":140,"activeCount":100},[],{"intervention":51,"totalTrials":96,"cells":142},{"EARLY_PHASE1":143,"PHASE1":145,"PHASE2":147,"PHASE3":162,"PHASE4":164,"NA":166},{"trials":144,"activeCount":100},[],{"trials":146,"activeCount":100},[],{"trials":148,"activeCount":96,"soonestReadout":50},[149],{"nctId":48,"briefTitle":49,"status":150,"phases":151,"primaryCompletion":50,"completion":152,"start":153,"enrollment":154,"conditions":155,"interventions":160},"RECRUITING",[90],"2025-12-31","2024-07-14",100,[156,157,158,159],"West Nile Virus","West Nile Fever Encephalitis","West Nile Fever Myelitis","West Nile Fever With Other Complications",[51,161],"Saline",{"trials":163,"activeCount":100},[],{"trials":165,"activeCount":100},[],{"trials":167,"activeCount":100},[],{"intervention":61,"totalTrials":96,"cells":169},{"EARLY_PHASE1":170,"PHASE1":172,"PHASE2":174,"PHASE3":186,"PHASE4":188,"NA":190},{"trials":171,"activeCount":100},[],{"trials":173,"activeCount":100},[],{"trials":175,"activeCount":96,"soonestReadout":60},[176],{"nctId":58,"briefTitle":59,"status":177,"phases":178,"primaryCompletion":60,"completion":179,"start":180,"enrollment":181,"conditions":182,"interventions":185},"ACTIVE_NOT_RECRUITING",[90],"2029-09-01","2021-03-25",61,[183,184],"Multiple Myeloma in Relapse","Refractory Multiple Myeloma",[61],{"trials":187,"activeCount":100},[],{"trials":189,"activeCount":100},[],{"trials":191,"activeCount":100},[],{"intervention":193,"totalTrials":96,"cells":194},"Mosunetuzumab is a bispecific monoclonal antibody targeting CD20 on B cells and CD3 on T cells, redirecting T cells to eliminate malignant B cells.",{"EARLY_PHASE1":195,"PHASE1":197,"PHASE2":199,"PHASE3":212,"PHASE4":214,"NA":216},{"trials":196,"activeCount":100},[],{"trials":198,"activeCount":100},[],{"trials":200,"activeCount":96,"soonestReadout":205},[201],{"nctId":202,"briefTitle":203,"status":110,"phases":204,"primaryCompletion":205,"completion":206,"start":207,"enrollment":208,"conditions":209,"interventions":211},"NCT07191249","A Phase 2, Multicenter, Open-Label Trial to Evaluate Efficacy and Safety of Subcutaneous (SC) Mosunetuzumab in Previously Untreated Low Tumor Burden Follicular Lymphoma (LTB-FL).",[90],"2028-04-01","2029-03-01","2025-10-10",30,[210],"Follicular Lymphoma",[193],{"trials":213,"activeCount":100},[],{"trials":215,"activeCount":100},[],{"trials":217,"activeCount":100},[],{"intervention":66,"totalTrials":96,"cells":219},{"EARLY_PHASE1":220,"PHASE1":222,"PHASE2":224,"PHASE3":234,"PHASE4":236,"NA":238},{"trials":221,"activeCount":100},[],{"trials":223,"activeCount":100},[],{"trials":225,"activeCount":96,"soonestReadout":65},[226],{"nctId":63,"briefTitle":64,"status":150,"phases":227,"primaryCompletion":65,"completion":65,"start":228,"enrollment":229,"conditions":230,"interventions":233},[90],"2025-03-12",60,[231,232],"Ovarian Cancer","Ovarian Cancer Metastatic Recurrent",[66],{"trials":235,"activeCount":100},[],{"trials":237,"activeCount":100},[],{"trials":239,"activeCount":100},[],{"intervention":46,"totalTrials":96,"cells":241},{"EARLY_PHASE1":242,"PHASE1":244,"PHASE2":246,"PHASE3":256,"PHASE4":258,"NA":260},{"trials":243,"activeCount":100},[],{"trials":245,"activeCount":100},[],{"trials":247,"activeCount":96,"soonestReadout":45},[248],{"nctId":43,"briefTitle":44,"status":150,"phases":249,"primaryCompletion":45,"completion":250,"start":251,"enrollment":208,"conditions":252,"interventions":254},[89,90],"2026-07-01","2018-09-26",[253],"Helicobacter Pylori Infection",[46,255],"Auto Fecal Microbial Transplant (FMT) via enema",{"trials":257,"activeCount":100},[],{"trials":259,"activeCount":100},[],{"trials":261,"activeCount":100},[],{"intervention":255,"totalTrials":96,"cells":263},{"EARLY_PHASE1":264,"PHASE1":266,"PHASE2":268,"PHASE3":274,"PHASE4":276,"NA":278},{"trials":265,"activeCount":100},[],{"trials":267,"activeCount":100},[],{"trials":269,"activeCount":96,"soonestReadout":45},[270],{"nctId":43,"briefTitle":44,"status":150,"phases":271,"primaryCompletion":45,"completion":250,"start":251,"enrollment":208,"conditions":272,"interventions":273},[89,90],[253],[46,255],{"trials":275,"activeCount":100},[],{"trials":277,"activeCount":100},[],{"trials":279,"activeCount":100},[],{"intervention":161,"totalTrials":281,"cells":282},3,{"EARLY_PHASE1":283,"PHASE1":285,"PHASE2":287,"PHASE3":293,"PHASE4":308,"NA":310},{"trials":284,"activeCount":100},[],{"trials":286,"activeCount":100},[],{"trials":288,"activeCount":96,"soonestReadout":50},[289],{"nctId":48,"briefTitle":49,"status":150,"phases":290,"primaryCompletion":50,"completion":152,"start":153,"enrollment":154,"conditions":291,"interventions":292},[90],[156,157,158,159],[51,161],{"trials":294,"activeCount":100},[295],{"nctId":296,"briefTitle":297,"status":298,"phases":299,"primaryCompletion":300,"completion":300,"start":301,"enrollment":154,"conditions":302,"interventions":306},"NCT02037503","The Effect of Ketamine on Mechanises Underlying Suicidal Ideation and Drug-resistant Major Depression","UNKNOWN",[91],"2020-05","2014-01",[303,304,305],"Suicidal Ideation","Major Depressive Disorder","Healthy Participants",[307,161],"Ketamine",{"trials":309,"activeCount":100},[],{"trials":311,"activeCount":100},[312],{"nctId":313,"briefTitle":314,"status":298,"phases":315,"primaryCompletion":316,"completion":316,"start":317,"enrollment":154,"conditions":318,"interventions":320},"NCT01308359","Use of Glucose and Saline for Fetal Movement Perception",[93],"2012-01","2011-01",[319],"Fetal Movement Perception",[321,322],"IV glucose 5%","saline",{"intervention":76,"totalTrials":96,"cells":324},{"EARLY_PHASE1":325,"PHASE1":327,"PHASE2":337,"PHASE3":339,"PHASE4":341,"NA":343},{"trials":326,"activeCount":100},[],{"trials":328,"activeCount":96,"soonestReadout":75},[329],{"nctId":73,"briefTitle":74,"status":150,"phases":330,"primaryCompletion":75,"completion":331,"start":332,"enrollment":333,"conditions":334,"interventions":336},[89],"2028-02","2026-05",12,[335],"Large B-Cell Lymphoma (LBCL)",[76],{"trials":338,"activeCount":100},[],{"trials":340,"activeCount":100},[],{"trials":342,"activeCount":100},[],{"trials":344,"activeCount":100},[],{"intervention":41,"totalTrials":346,"cells":347},4,{"EARLY_PHASE1":348,"PHASE1":350,"PHASE2":352,"PHASE3":354,"PHASE4":366,"NA":381},{"trials":349,"activeCount":100},[],{"trials":351,"activeCount":100},[],{"trials":353,"activeCount":100},[],{"trials":355,"activeCount":100},[356],{"nctId":357,"briefTitle":358,"status":298,"phases":359,"primaryCompletion":360,"completion":360,"start":361,"enrollment":362,"conditions":363,"interventions":365},"NCT03511833","Comparison of Treatment by IN Ketamine to IV Morphine in Acute Pain",[91],"2021-12","2019-12",120,[364],"Acute Traumatic Pain",[41,307],{"trials":367,"activeCount":100},[368],{"nctId":369,"briefTitle":370,"status":298,"phases":371,"primaryCompletion":372,"completion":373,"start":374,"enrollment":375,"conditions":376,"interventions":378},"NCT01129934","Morphine Versus Morphine-promethazine Combination for Acute Low Back Pain Relief in the Adult Emergency Department",[92],"2011-12","2013-01","2010-05",200,[377],"Low Back Pain",[379,380],"Morphine-Promethazine","morphine",{"trials":382,"activeCount":96,"soonestReadout":40},[383,393],{"nctId":38,"briefTitle":39,"status":177,"phases":384,"primaryCompletion":40,"completion":40,"start":385,"enrollment":386,"conditions":387,"interventions":391},[93],"2022-02-16",115,[388,389,390],"Pain, Postoperative","Anesthesia","Analgesia",[41,392],"Nacl 0.9%",{"nctId":394,"briefTitle":395,"status":396,"phases":397,"primaryCompletion":398,"completion":398,"start":399,"enrollment":400,"conditions":401,"interventions":403},"NCT00625911","Ketamine Improves Post-Thoracotomy Analgesia","COMPLETED",[93],"2002-03","2001-09",44,[402],"Post Operative Pain",[380,404],"morphine ketamine",{"intervention":392,"totalTrials":96,"cells":406},{"EARLY_PHASE1":407,"PHASE1":409,"PHASE2":411,"PHASE3":413,"PHASE4":415,"NA":417},{"trials":408,"activeCount":100},[],{"trials":410,"activeCount":100},[],{"trials":412,"activeCount":100},[],{"trials":414,"activeCount":100},[],{"trials":416,"activeCount":100},[],{"trials":418,"activeCount":96,"soonestReadout":40},[419],{"nctId":38,"briefTitle":39,"status":177,"phases":420,"primaryCompletion":40,"completion":40,"start":385,"enrollment":386,"conditions":421,"interventions":422},[93],[388,389,390],[41,392],{"intervention":71,"totalTrials":96,"cells":424},{"EARLY_PHASE1":425,"PHASE1":427,"PHASE2":429,"PHASE3":431,"PHASE4":433,"NA":435},{"trials":426,"activeCount":100},[],{"trials":428,"activeCount":100},[],{"trials":430,"activeCount":100},[],{"trials":432,"activeCount":100},[],{"trials":434,"activeCount":100},[],{"trials":436,"activeCount":96,"soonestReadout":70},[437],{"nctId":68,"briefTitle":69,"status":110,"phases":438,"primaryCompletion":70,"completion":70,"start":439,"enrollment":440,"conditions":441,"interventions":443},[93],"2024-09",64,[442],"Motoric Cognitive Risk Syndrome",[71],{"intervention":445,"totalTrials":96,"cells":446},"Transdermal fentanyl patch",{"EARLY_PHASE1":447,"PHASE1":449,"PHASE2":451,"PHASE3":453,"PHASE4":455,"NA":457},{"trials":448,"activeCount":100},[],{"trials":450,"activeCount":100},[],{"trials":452,"activeCount":100},[],{"trials":454,"activeCount":100},[],{"trials":456,"activeCount":100},[],{"trials":458,"activeCount":96,"soonestReadout":463},[459],{"nctId":460,"briefTitle":461,"status":150,"phases":462,"primaryCompletion":463,"completion":463,"start":464,"enrollment":8,"conditions":465,"interventions":468},"NCT06966869","Evaluation of Fentanyl Transdermal Patch Absorption in Hemodynamically Unstable ICU Patients.",[],"2028-04-22","2025-04-22",[466,467],"Pain Management","Critical Illness",[445,445],{"intervention":81,"totalTrials":96,"cells":470},{"EARLY_PHASE1":471,"PHASE1":473,"PHASE2":475,"PHASE3":477,"PHASE4":479,"NA":481},{"trials":472,"activeCount":100},[],{"trials":474,"activeCount":100},[],{"trials":476,"activeCount":100},[],{"trials":478,"activeCount":100},[],{"trials":480,"activeCount":100},[],{"trials":482,"activeCount":96,"soonestReadout":80},[483],{"nctId":78,"briefTitle":79,"status":150,"phases":484,"primaryCompletion":80,"completion":485,"start":486,"enrollment":375,"conditions":487,"interventions":490},[93],"2027-06","2025-05-21",[488,489],"ST Segment Elevation Myocardial Infarction (STEMI)","Cardiogenic Shock Post Myocardial Infarction",[81,491],"Plcacebo",{"intervention":491,"totalTrials":96,"cells":493},{"EARLY_PHASE1":494,"PHASE1":496,"PHASE2":498,"PHASE3":500,"PHASE4":502,"NA":504},{"trials":495,"activeCount":100},[],{"trials":497,"activeCount":100},[],{"trials":499,"activeCount":100},[],{"trials":501,"activeCount":100},[],{"trials":503,"activeCount":100},[],{"trials":505,"activeCount":96,"soonestReadout":80},[506],{"nctId":78,"briefTitle":79,"status":150,"phases":507,"primaryCompletion":80,"completion":485,"start":486,"enrollment":375,"conditions":508,"interventions":509},[93],[488,489],[81,491],{"intervention":511,"totalTrials":512,"cells":513},"Tocilizumab",2,{"EARLY_PHASE1":514,"PHASE1":516,"PHASE2":518,"PHASE3":529,"PHASE4":531,"NA":543},{"trials":515,"activeCount":100},[],{"trials":517,"activeCount":100},[],{"trials":519,"activeCount":100},[520],{"nctId":521,"briefTitle":522,"status":298,"phases":523,"primaryCompletion":524,"completion":524,"start":525,"enrollment":19,"conditions":526,"interventions":528},"NCT01002781","Efficacy and Safety of Tocilizumab in Adult's Still Disease",[90],"2011-07","2009-11",[527],"Adult's Still Disease",[511],{"trials":530,"activeCount":100},[],{"trials":532,"activeCount":100},[533],{"nctId":534,"briefTitle":535,"status":298,"phases":536,"primaryCompletion":537,"completion":361,"start":538,"enrollment":539,"conditions":540,"interventions":542},"NCT03781310","Therapeutic Drug Monitoring of Tocilizumab in Rheumatoid Arthritis",[92],"2019-06-30","2018-12",80,[541,511],"Rheumatoid Arthritis",[511],{"trials":544,"activeCount":100},[],{"intervention":546,"totalTrials":96,"cells":547},"Ketamine\u002FMidazolam",{"EARLY_PHASE1":548,"PHASE1":550,"PHASE2":552,"PHASE3":554,"PHASE4":556,"NA":568},{"trials":549,"activeCount":100},[],{"trials":551,"activeCount":100},[],{"trials":553,"activeCount":100},[],{"trials":555,"activeCount":100},[],{"trials":557,"activeCount":100},[558],{"nctId":559,"briefTitle":560,"status":396,"phases":561,"primaryCompletion":562,"completion":562,"start":563,"enrollment":229,"conditions":564,"interventions":566},"NCT00784498","Procedural Sedation Using Propofol Versus Midazolam\u002FKetamine in the Adult Emergency Department",[92],"2009-09","2008-11",[565],"Procedural Sedation",[546,567],"Propofol",{"trials":569,"activeCount":100},[],{"intervention":571,"totalTrials":96,"cells":572},"omeprazole, 20mg twice daily",{"EARLY_PHASE1":573,"PHASE1":575,"PHASE2":577,"PHASE3":579,"PHASE4":581,"NA":597},{"trials":574,"activeCount":100},[],{"trials":576,"activeCount":100},[],{"trials":578,"activeCount":100},[],{"trials":580,"activeCount":100},[],{"trials":582,"activeCount":100},[583],{"nctId":584,"briefTitle":585,"status":396,"phases":586,"primaryCompletion":587,"completion":588,"start":589,"enrollment":590,"conditions":591,"interventions":594},"NCT00950339","Platelet Inhibitory Effect of Clopidogrel in Patients Treated With Omeprazole, Pantoprazole, or Famotidine",[92],"2011-06","2011-08","2009-08",63,[592,593],"Coronary Heart Disease","GI Bleeding",[571,595,596],"famotidine 40mg twice daily","pantoprazole 40mg once daily",{"trials":598,"activeCount":100},[],{"intervention":595,"totalTrials":96,"cells":600},{"EARLY_PHASE1":601,"PHASE1":603,"PHASE2":605,"PHASE3":607,"PHASE4":609,"NA":615},{"trials":602,"activeCount":100},[],{"trials":604,"activeCount":100},[],{"trials":606,"activeCount":100},[],{"trials":608,"activeCount":100},[],{"trials":610,"activeCount":100},[611],{"nctId":584,"briefTitle":585,"status":396,"phases":612,"primaryCompletion":587,"completion":588,"start":589,"enrollment":590,"conditions":613,"interventions":614},[92],[592,593],[571,595,596],{"trials":616,"activeCount":100},[],{"intervention":596,"totalTrials":96,"cells":618},{"EARLY_PHASE1":619,"PHASE1":621,"PHASE2":623,"PHASE3":625,"PHASE4":627,"NA":633},{"trials":620,"activeCount":100},[],{"trials":622,"activeCount":100},[],{"trials":624,"activeCount":100},[],{"trials":626,"activeCount":100},[],{"trials":628,"activeCount":100},[629],{"nctId":584,"briefTitle":585,"status":396,"phases":630,"primaryCompletion":587,"completion":588,"start":589,"enrollment":590,"conditions":631,"interventions":632},[92],[592,593],[571,595,596],{"trials":634,"activeCount":100},[],{"intervention":636,"totalTrials":96,"cells":637},"Conventional Treatment",{"EARLY_PHASE1":638,"PHASE1":640,"PHASE2":642,"PHASE3":644,"PHASE4":646,"NA":660},{"trials":639,"activeCount":100},[],{"trials":641,"activeCount":100},[],{"trials":643,"activeCount":100},[],{"trials":645,"activeCount":100},[],{"trials":647,"activeCount":100},[648],{"nctId":649,"briefTitle":650,"status":396,"phases":651,"primaryCompletion":652,"completion":653,"start":654,"enrollment":655,"conditions":656,"interventions":659},"NCT01866800","The Effect of the Forced Diuresis With Matched Hydration in Reducing Acute Kidney Injury During TAVI",[92],"2019-04-01","2019-05-22","2013-06-01",136,[657,658],"Radiographic Contrast Agent Nephropathy","Aortic Valve Stenosis With Insufficiency",[636],{"trials":661,"activeCount":100},[],{"intervention":663,"totalTrials":96,"cells":664},"Seasonal influenza vaccine",{"EARLY_PHASE1":665,"PHASE1":667,"PHASE2":669,"PHASE3":671,"PHASE4":673,"NA":684},{"trials":666,"activeCount":100},[],{"trials":668,"activeCount":100},[],{"trials":670,"activeCount":100},[],{"trials":672,"activeCount":100},[],{"trials":674,"activeCount":100},[675],{"nctId":676,"briefTitle":677,"status":298,"phases":678,"primaryCompletion":679,"completion":679,"start":680,"enrollment":8,"conditions":681,"interventions":683},"NCT01980836","Effect of Tocilizumab to the Cellular Immune Response to Influenza Vaccine",[92],"2014-02","2013-11",[541,682],"Cellular Immune Response",[663],{"trials":685,"activeCount":100},[],{"intervention":687,"totalTrials":96,"cells":688},"Misoprostol",{"EARLY_PHASE1":689,"PHASE1":691,"PHASE2":693,"PHASE3":695,"PHASE4":697,"NA":710},{"trials":690,"activeCount":100},[],{"trials":692,"activeCount":100},[],{"trials":694,"activeCount":100},[],{"trials":696,"activeCount":100},[],{"trials":698,"activeCount":100},[699],{"nctId":700,"briefTitle":701,"status":396,"phases":702,"primaryCompletion":703,"completion":704,"start":705,"enrollment":706,"conditions":707,"interventions":709},"NCT04685694","Management of RPOC After Induced Abortion",[92],"2021-12-31","2022-01-31","2020-01-01",141,[708],"Abortion Induced Complicated",[687],{"trials":711,"activeCount":100},[],{"intervention":713,"totalTrials":96,"cells":714},"Azithromycin",{"EARLY_PHASE1":715,"PHASE1":717,"PHASE2":719,"PHASE3":721,"PHASE4":723,"NA":735},{"trials":716,"activeCount":100},[],{"trials":718,"activeCount":100},[],{"trials":720,"activeCount":100},[],{"trials":722,"activeCount":100},[],{"trials":724,"activeCount":100},[725],{"nctId":726,"briefTitle":727,"status":298,"phases":728,"primaryCompletion":729,"completion":730,"start":731,"enrollment":19,"conditions":732,"interventions":734},"NCT04454151","Azithromycin Treatment for Readthrough of APC Gene Stop Codon Mutations in Familial Adenomatous Polyposis",[92],"2022-01-01","2022-04-01","2020-08-01",[733],"Familial Adenomatous Polyposis",[713],{"trials":736,"activeCount":100},[],{"intervention":738,"totalTrials":96,"cells":739},"Piperacillin\u002Ftazobactam",{"EARLY_PHASE1":740,"PHASE1":742,"PHASE2":744,"PHASE3":746,"PHASE4":748,"NA":765},{"trials":741,"activeCount":100},[],{"trials":743,"activeCount":100},[],{"trials":745,"activeCount":100},[],{"trials":747,"activeCount":100},[],{"trials":749,"activeCount":100},[750],{"nctId":751,"briefTitle":752,"status":298,"phases":753,"primaryCompletion":754,"completion":755,"start":756,"enrollment":757,"conditions":758,"interventions":761},"NCT02463747","Short vs Prolonged Antibiotic Treatment for Hospitalized Hemato-oncology Patients With Febrile Neutropenia",[92],"2017-06","2017-07","2015-06",110,[759,760],"Fever","Febrile Neutropenia",[738,762,763,764],"Ceftazidim","Meropenem","Vancomycin",{"trials":766,"activeCount":100},[],{"intervention":762,"totalTrials":96,"cells":768},{"EARLY_PHASE1":769,"PHASE1":771,"PHASE2":773,"PHASE3":775,"PHASE4":777,"NA":783},{"trials":770,"activeCount":100},[],{"trials":772,"activeCount":100},[],{"trials":774,"activeCount":100},[],{"trials":776,"activeCount":100},[],{"trials":778,"activeCount":100},[779],{"nctId":751,"briefTitle":752,"status":298,"phases":780,"primaryCompletion":754,"completion":755,"start":756,"enrollment":757,"conditions":781,"interventions":782},[92],[759,760],[738,762,763,764],{"trials":784,"activeCount":100},[],{"intervention":763,"totalTrials":96,"cells":786},{"EARLY_PHASE1":787,"PHASE1":789,"PHASE2":791,"PHASE3":793,"PHASE4":795,"NA":801},{"trials":788,"activeCount":100},[],{"trials":790,"activeCount":100},[],{"trials":792,"activeCount":100},[],{"trials":794,"activeCount":100},[],{"trials":796,"activeCount":100},[797],{"nctId":751,"briefTitle":752,"status":298,"phases":798,"primaryCompletion":754,"completion":755,"start":756,"enrollment":757,"conditions":799,"interventions":800},[92],[759,760],[738,762,763,764],{"trials":802,"activeCount":100},[],{"intervention":764,"totalTrials":96,"cells":804},{"EARLY_PHASE1":805,"PHASE1":807,"PHASE2":809,"PHASE3":811,"PHASE4":813,"NA":819},{"trials":806,"activeCount":100},[],{"trials":808,"activeCount":100},[],{"trials":810,"activeCount":100},[],{"trials":812,"activeCount":100},[],{"trials":814,"activeCount":100},[815],{"nctId":751,"briefTitle":752,"status":298,"phases":816,"primaryCompletion":754,"completion":755,"start":756,"enrollment":757,"conditions":817,"interventions":818},[92],[759,760],[738,762,763,764],{"trials":820,"activeCount":100},[],{"intervention":379,"totalTrials":96,"cells":822},{"EARLY_PHASE1":823,"PHASE1":825,"PHASE2":827,"PHASE3":829,"PHASE4":831,"NA":837},{"trials":824,"activeCount":100},[],{"trials":826,"activeCount":100},[],{"trials":828,"activeCount":100},[],{"trials":830,"activeCount":100},[],{"trials":832,"activeCount":100},[833],{"nctId":369,"briefTitle":370,"status":298,"phases":834,"primaryCompletion":372,"completion":373,"start":374,"enrollment":375,"conditions":835,"interventions":836},[92],[377],[379,380],{"trials":838,"activeCount":100},[],{"intervention":840,"totalTrials":96,"cells":841},"Busulfan\u002FCyclophosphamide",{"EARLY_PHASE1":842,"PHASE1":844,"PHASE2":846,"PHASE3":848,"PHASE4":850,"NA":864},{"trials":843,"activeCount":100},[],{"trials":845,"activeCount":100},[],{"trials":847,"activeCount":100},[],{"trials":849,"activeCount":100},[],{"trials":851,"activeCount":100},[852],{"nctId":853,"briefTitle":854,"status":298,"phases":855,"primaryCompletion":856,"completion":857,"start":587,"enrollment":19,"conditions":858,"interventions":863},"NCT01339988","Busulfan and Cyclophosphamide Instead of Total Boby Irradiation (TBI) and Cyclophosphamide for Hematological Malignancies Hematocrit (HCT)",[92],"2014-06","2019-06",[859,860,861,862],"Acute Leukemias","Chronic Leukemias","Myelodysplastic Syndrome","Juvenile Myelomonocytic Leukemia",[840],{"trials":865,"activeCount":100},[],{"intervention":867,"totalTrials":96,"cells":868},"Empagliflozin 10 MG",{"EARLY_PHASE1":869,"PHASE1":871,"PHASE2":873,"PHASE3":875,"PHASE4":877,"NA":890},{"trials":870,"activeCount":100},[],{"trials":872,"activeCount":100},[],{"trials":874,"activeCount":100},[],{"trials":876,"activeCount":100},[],{"trials":878,"activeCount":100},[879],{"nctId":880,"briefTitle":881,"status":396,"phases":882,"primaryCompletion":883,"completion":883,"start":884,"enrollment":154,"conditions":885,"interventions":889},"NCT03560375","Mediterranean Diet, Circuit Resistance Training, Empagliflozin in Elderly With Type 2 Diabetes: a Study Protocol",[92],"2021-02-10","2018-05-09",[886,887,888],"Diabetes Mellitus, Type 2","Sarcopenia","Weight Loss",[867],{"trials":891,"activeCount":100},[],{"intervention":893,"totalTrials":96,"cells":894},"40mg Enoxaparin",{"EARLY_PHASE1":895,"PHASE1":897,"PHASE2":899,"PHASE3":901,"PHASE4":903,"NA":915},{"trials":896,"activeCount":100},[],{"trials":898,"activeCount":100},[],{"trials":900,"activeCount":100},[],{"trials":902,"activeCount":100},[],{"trials":904,"activeCount":100},[905],{"nctId":906,"briefTitle":907,"status":298,"phases":908,"primaryCompletion":909,"completion":910,"start":680,"enrollment":911,"conditions":912,"interventions":913},"NCT01970202","Anti Xa Levels Under Two Different Regimens of Enoxaparin VTE Prophylaxis After Sleeve Gastrectomy for Morbid Obesity",[92],"2015-12","2016-07",55,[24],[893,914],"60mg Enoxaparin",{"trials":916,"activeCount":100},[],{"intervention":914,"totalTrials":96,"cells":918},{"EARLY_PHASE1":919,"PHASE1":921,"PHASE2":923,"PHASE3":925,"PHASE4":927,"NA":933},{"trials":920,"activeCount":100},[],{"trials":922,"activeCount":100},[],{"trials":924,"activeCount":100},[],{"trials":926,"activeCount":100},[],{"trials":928,"activeCount":100},[929],{"nctId":906,"briefTitle":907,"status":298,"phases":930,"primaryCompletion":909,"completion":910,"start":680,"enrollment":911,"conditions":931,"interventions":932},[92],[24],[893,914],{"trials":934,"activeCount":100},[],{"intervention":936,"totalTrials":96,"cells":937},"non-drug cream",{"EARLY_PHASE1":938,"PHASE1":940,"PHASE2":942,"PHASE3":944,"PHASE4":946,"NA":961},{"trials":939,"activeCount":100},[],{"trials":941,"activeCount":100},[],{"trials":943,"activeCount":100},[],{"trials":945,"activeCount":100},[],{"trials":947,"activeCount":100},[948],{"nctId":949,"briefTitle":950,"status":298,"phases":951,"primaryCompletion":952,"completion":953,"start":954,"enrollment":955,"conditions":956,"interventions":958},"NCT00822419","Percutaneous Ketamine Versus Lidocaine for Mid-Sternotomy",[92],"2009-06","2009-12","2009-02",75,[957],"Sternotomy",[959,960,936],"lidocaine","ketamine",{"trials":962,"activeCount":100},[],{"intervention":964,"totalTrials":96,"cells":965},"Allopurinol",{"EARLY_PHASE1":966,"PHASE1":968,"PHASE2":970,"PHASE3":972,"PHASE4":974,"NA":988},{"trials":967,"activeCount":100},[],{"trials":969,"activeCount":100},[],{"trials":971,"activeCount":100},[],{"trials":973,"activeCount":100},[],{"trials":975,"activeCount":100},[976],{"nctId":977,"briefTitle":978,"status":298,"phases":979,"primaryCompletion":980,"completion":981,"start":982,"enrollment":154,"conditions":983,"interventions":987},"NCT03700645","Allopurinol in Diabetes Mellitus and Multivessel Coronary Artery Disease",[92],"2019-12-31","2020-01-31","2018-12-01",[984,985,986],"Diabetes Mellitus","Ischemic Heart Disease","Multi Vessel Coronary Artery Disease",[964],{"trials":989,"activeCount":100},[],{"intervention":991,"totalTrials":96,"cells":992},"Bupivacaine",{"EARLY_PHASE1":993,"PHASE1":995,"PHASE2":997,"PHASE3":999,"PHASE4":1001,"NA":1013},{"trials":994,"activeCount":100},[],{"trials":996,"activeCount":100},[],{"trials":998,"activeCount":100},[],{"trials":1000,"activeCount":100},[],{"trials":1002,"activeCount":100},[1003],{"nctId":1004,"briefTitle":1005,"status":396,"phases":1006,"primaryCompletion":1007,"completion":1007,"start":731,"enrollment":1008,"conditions":1009,"interventions":1011},"NCT04251962","Role of Opioids in Epidural Solutions",[92],"2022-03-02",135,[1010],"Postoperative Pain",[991,1012],"Fentanyl",{"trials":1014,"activeCount":100},[],{"intervention":1012,"totalTrials":96,"cells":1016},{"EARLY_PHASE1":1017,"PHASE1":1019,"PHASE2":1021,"PHASE3":1023,"PHASE4":1025,"NA":1031},{"trials":1018,"activeCount":100},[],{"trials":1020,"activeCount":100},[],{"trials":1022,"activeCount":100},[],{"trials":1024,"activeCount":100},[],{"trials":1026,"activeCount":100},[1027],{"nctId":1004,"briefTitle":1005,"status":396,"phases":1028,"primaryCompletion":1007,"completion":1007,"start":731,"enrollment":1008,"conditions":1029,"interventions":1030},[92],[1010],[991,1012],{"trials":1032,"activeCount":100},[],{"intervention":1034,"totalTrials":96,"cells":1035},"Plerixafor",{"EARLY_PHASE1":1036,"PHASE1":1038,"PHASE2":1040,"PHASE3":1042,"PHASE4":1044,"NA":1055},{"trials":1037,"activeCount":100},[],{"trials":1039,"activeCount":100},[],{"trials":1041,"activeCount":100},[],{"trials":1043,"activeCount":100},[],{"trials":1045,"activeCount":100},[1046],{"nctId":1047,"briefTitle":1048,"status":298,"phases":1049,"primaryCompletion":1050,"completion":1051,"start":679,"enrollment":208,"conditions":1052,"interventions":1054},"NCT02006225","Stem Cell Harvesting Using GCSF Plus Plerxiafor, in First -Line, for Heavily Pre- Treated Pediatric Oncology Patients.",[92],"2019-02","2020-02",[1053],"Autologous Stem Cell Transplantation",[1034],{"trials":1056,"activeCount":100},[],{"intervention":1058,"totalTrials":96,"cells":1059},"Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed)",{"EARLY_PHASE1":1060,"PHASE1":1062,"PHASE2":1064,"PHASE3":1066,"PHASE4":1068,"NA":1078},{"trials":1061,"activeCount":100},[],{"trials":1063,"activeCount":100},[],{"trials":1065,"activeCount":100},[],{"trials":1067,"activeCount":100},[],{"trials":1069,"activeCount":100},[1070],{"nctId":1071,"briefTitle":1072,"status":298,"phases":1073,"primaryCompletion":372,"completion":1074,"start":1075,"enrollment":154,"conditions":1076,"interventions":1077},"NCT01301703","Vaccination Against Pertussis, Tetanus and Diphtheria in Patients Suffering From Rheumatoid Arthritis",[92],"2012-02","2011-03",[541],[1058],{"trials":1079,"activeCount":100},[],{"intervention":1081,"totalTrials":96,"cells":1082},"Agrippal S1",{"EARLY_PHASE1":1083,"PHASE1":1085,"PHASE2":1087,"PHASE3":1089,"PHASE4":1091,"NA":1103},{"trials":1084,"activeCount":100},[],{"trials":1086,"activeCount":100},[],{"trials":1088,"activeCount":100},[],{"trials":1090,"activeCount":100},[],{"trials":1092,"activeCount":100},[1093],{"nctId":1094,"briefTitle":1095,"status":298,"phases":1096,"primaryCompletion":1097,"completion":1098,"start":1099,"enrollment":1100,"conditions":1101,"interventions":1102},"NCT01002716","Cell Immunity Response to Vaccination Against Influenza in Patients With Rheumatoid Arthritis",[92],"2010-03","2010-04","2009-10",90,[541],[1081],{"trials":1104,"activeCount":100},[],{"intervention":1106,"totalTrials":96,"cells":1107},"Iron Carboxymaltose",{"EARLY_PHASE1":1108,"PHASE1":1110,"PHASE2":1112,"PHASE3":1114,"PHASE4":1116,"NA":1128},{"trials":1109,"activeCount":100},[],{"trials":1111,"activeCount":100},[],{"trials":1113,"activeCount":100},[],{"trials":1115,"activeCount":100},[],{"trials":1117,"activeCount":100},[1118],{"nctId":1119,"briefTitle":1120,"status":1121,"phases":1122,"primaryCompletion":1123,"completion":1123,"start":1124,"enrollment":100,"conditions":1125,"interventions":1127},"NCT03042130","Treatment With IV Iron in Hospitalized Patients With Severe Heart Failure But Without Iron Deficiency","WITHDRAWN",[92],"2018-02-06","2016-12-14",[1126],"Heart Failure",[1106],{"trials":1129,"activeCount":100},[],{"intervention":1131,"totalTrials":96,"cells":1132},"prednison and azithromycin",{"EARLY_PHASE1":1133,"PHASE1":1135,"PHASE2":1137,"PHASE3":1139,"PHASE4":1141,"NA":1154},{"trials":1134,"activeCount":100},[],{"trials":1136,"activeCount":100},[],{"trials":1138,"activeCount":100},[],{"trials":1140,"activeCount":100},[],{"trials":1142,"activeCount":100},[1143],{"nctId":1144,"briefTitle":1145,"status":298,"phases":1146,"primaryCompletion":1147,"start":372,"enrollment":19,"conditions":1148,"interventions":1151},"NCT01469702","The Efficacy of Prednisone and Azithromycin in the Treatment of Patients With Cat Scratch Disease",[92],"2012-08",[1149,1150],"Cat-scratch Disease","Bartonella Infections",[1131,1152,1153],"prednison, azithromycin","prednison, Azenil",{"trials":1155,"activeCount":100},[],{"intervention":1152,"totalTrials":96,"cells":1157},{"EARLY_PHASE1":1158,"PHASE1":1160,"PHASE2":1162,"PHASE3":1164,"PHASE4":1166,"NA":1172},{"trials":1159,"activeCount":100},[],{"trials":1161,"activeCount":100},[],{"trials":1163,"activeCount":100},[],{"trials":1165,"activeCount":100},[],{"trials":1167,"activeCount":100},[1168],{"nctId":1144,"briefTitle":1145,"status":298,"phases":1169,"primaryCompletion":1147,"start":372,"enrollment":19,"conditions":1170,"interventions":1171},[92],[1149,1150],[1131,1152,1153],{"trials":1173,"activeCount":100},[],{"intervention":1153,"totalTrials":96,"cells":1175},{"EARLY_PHASE1":1176,"PHASE1":1178,"PHASE2":1180,"PHASE3":1182,"PHASE4":1184,"NA":1190},{"trials":1177,"activeCount":100},[],{"trials":1179,"activeCount":100},[],{"trials":1181,"activeCount":100},[],{"trials":1183,"activeCount":100},[],{"trials":1185,"activeCount":100},[1186],{"nctId":1144,"briefTitle":1145,"status":298,"phases":1187,"primaryCompletion":1147,"start":372,"enrollment":19,"conditions":1188,"interventions":1189},[92],[1149,1150],[1131,1152,1153],{"trials":1191,"activeCount":100},[],{"intervention":1193,"totalTrials":96,"cells":1194},"non-active drug cream",{"EARLY_PHASE1":1195,"PHASE1":1197,"PHASE2":1199,"PHASE3":1201,"PHASE4":1203,"NA":1211},{"trials":1196,"activeCount":100},[],{"trials":1198,"activeCount":100},[],{"trials":1200,"activeCount":100},[],{"trials":1202,"activeCount":100},[],{"trials":1204,"activeCount":100},[1205],{"nctId":1206,"briefTitle":1207,"status":298,"phases":1208,"primaryCompletion":952,"completion":953,"start":954,"enrollment":955,"conditions":1209,"interventions":1210},"NCT00822133","Percutaneous Ketamine Versus Lidocaine or Placebo, for Post-Surgery Analgesia, in Patients Undergoing Laparoscopic Partial Lung Resection",[92],[1010],[959,960,1193],{"trials":1212,"activeCount":100},[],{"intervention":1214,"totalTrials":281,"cells":1215},"Fecal Microbial Transplantation",{"EARLY_PHASE1":1216,"PHASE1":1228,"PHASE2":1230,"PHASE3":1241,"PHASE4":1251,"NA":1253},{"trials":1217,"activeCount":100},[1218],{"nctId":1219,"briefTitle":1220,"status":396,"phases":1221,"primaryCompletion":1222,"completion":1222,"start":1223,"enrollment":1224,"conditions":1225,"interventions":1227},"NCT04613037","Efficacy of Fecal Microbial Transplantation Treatment in Adults With Atopic Dermatitis",[88],"2019-07-30","2017-11-01",15,[1226],"Atopic Dermatitis",[1214],{"trials":1229,"activeCount":100},[],{"trials":1231,"activeCount":100},[1232],{"nctId":1233,"briefTitle":1234,"status":298,"phases":1235,"primaryCompletion":1236,"completion":1236,"start":1237,"enrollment":8,"conditions":1238,"interventions":1240},"NCT04336319","Fecal Microbial Transplantation for Ileal Pouch Anal Anastomosis Patients",[90],"2024-12-31","2018-07-05",[1239],"Ileal Pouch Anal Anastomosis",[1214],{"trials":1242,"activeCount":100},[1243],{"nctId":1244,"briefTitle":1220,"status":298,"phases":1245,"primaryCompletion":1246,"completion":1247,"start":1248,"enrollment":114,"conditions":1249,"interventions":1250},"NCT04283968",[91],"2023-06-01","2024-06-01","2020-10-15",[1226],[1214],{"trials":1252,"activeCount":100},[],{"trials":1254,"activeCount":100},[],{"intervention":1256,"totalTrials":512,"cells":1257},"Intravenous oxytocin",{"EARLY_PHASE1":1258,"PHASE1":1260,"PHASE2":1262,"PHASE3":1264,"PHASE4":1288,"NA":1290},{"trials":1259,"activeCount":100},[],{"trials":1261,"activeCount":100},[],{"trials":1263,"activeCount":100},[],{"trials":1265,"activeCount":100},[1266,1277],{"nctId":1267,"briefTitle":1268,"status":298,"phases":1269,"primaryCompletion":1270,"completion":1270,"start":1271,"enrollment":1272,"conditions":1273,"interventions":1275},"NCT02720978","Tearing of Membranes Before Birth - a Comparison Between Two Ways of Induction of Labor Pitocin Opposite Prostaglandin",[91],"2019-05","2016-05",1200,[1274],"Fetus or Newborn or Maternal; Effects of Induction of Labor",[1256,1276],"vaginal prostaglandin",{"nctId":1278,"briefTitle":1279,"status":298,"phases":1280,"primaryCompletion":1281,"completion":1281,"start":1282,"enrollment":1283,"conditions":1284,"interventions":1286},"NCT02684305","Stepwise Labor Induction Following Failure of Prostaglandin Vaginal Insert for Labor Induction",[91],"2018-04","2016-04",320,[1285],"Induction of Labor",[1287,1256],"Administration of Propess",{"trials":1289,"activeCount":100},[],{"trials":1291,"activeCount":100},[],{"intervention":1293,"totalTrials":512,"cells":1294},"Curcumin",{"EARLY_PHASE1":1295,"PHASE1":1297,"PHASE2":1299,"PHASE3":1301,"PHASE4":1324,"NA":1326},{"trials":1296,"activeCount":100},[],{"trials":1298,"activeCount":100},[],{"trials":1300,"activeCount":100},[],{"trials":1302,"activeCount":100},[1303,1313],{"nctId":1304,"briefTitle":1305,"status":298,"phases":1306,"start":1307,"conditions":1308,"interventions":1310},"NCT00486460","Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer",[91],"2005-06",[1309],"Pancreatic Cancer",[1311,1293,1312],"Gemcitabine","Celebrex",{"nctId":1314,"briefTitle":1315,"status":298,"phases":1316,"completion":1317,"start":1318,"enrollment":154,"conditions":1319,"interventions":1321},"NCT00295035","Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Metastatic Colon Cancer",[91],"2007-03","2006-03",[1320],"Colon Neoplasm",[1322,1323],"CELECOXIB","CURCUMIN",{"trials":1325,"activeCount":100},[],{"trials":1327,"activeCount":100},[],{"intervention":1329,"totalTrials":96,"cells":1330},"Melatonin",{"EARLY_PHASE1":1331,"PHASE1":1333,"PHASE2":1335,"PHASE3":1337,"PHASE4":1348,"NA":1350},{"trials":1332,"activeCount":100},[],{"trials":1334,"activeCount":100},[],{"trials":1336,"activeCount":100},[],{"trials":1338,"activeCount":100},[1339],{"nctId":1340,"briefTitle":1341,"status":298,"phases":1342,"completion":1343,"start":1344,"enrollment":154,"conditions":1345,"interventions":1347},"NCT00261183","The Contribution of Melatonin Vs. Placebo in Benzodiazepine Withdrawal in Methadone Maintenance Treatment Patients",[91],"2006-12","2004-12",[1346],"Benzodiazepines",[1329],{"trials":1349,"activeCount":100},[],{"trials":1351,"activeCount":100},[],{"intervention":1353,"totalTrials":96,"cells":1354},"Sci-B-Vac Hepatitis B Vaccine",{"EARLY_PHASE1":1355,"PHASE1":1357,"PHASE2":1359,"PHASE3":1361,"PHASE4":1374,"NA":1376},{"trials":1356,"activeCount":100},[],{"trials":1358,"activeCount":100},[],{"trials":1360,"activeCount":100},[],{"trials":1362,"activeCount":100},[1363],{"nctId":1364,"briefTitle":1365,"status":298,"phases":1366,"primaryCompletion":1367,"start":1368,"enrollment":154,"conditions":1369,"interventions":1372},"NCT01933412","Efficacy and Safety of Hepatitis B Vaccine in Chronic Kidney Disease Patients",[91],"2013-08","2012-03",[1370,1371],"Chronic Kidney Disease","Hepatitis B",[1353,1373],"Engerix B Hepatitis B Vaccine",{"trials":1375,"activeCount":100},[],{"trials":1377,"activeCount":100},[],{"intervention":1373,"totalTrials":96,"cells":1379},{"EARLY_PHASE1":1380,"PHASE1":1382,"PHASE2":1384,"PHASE3":1386,"PHASE4":1392,"NA":1394},{"trials":1381,"activeCount":100},[],{"trials":1383,"activeCount":100},[],{"trials":1385,"activeCount":100},[],{"trials":1387,"activeCount":100},[1388],{"nctId":1364,"briefTitle":1365,"status":298,"phases":1389,"primaryCompletion":1367,"start":1368,"enrollment":154,"conditions":1390,"interventions":1391},[91],[1370,1371],[1353,1373],{"trials":1393,"activeCount":100},[],{"trials":1395,"activeCount":100},[],{"intervention":1397,"totalTrials":96,"cells":1398},"Semaglutide",{"EARLY_PHASE1":1399,"PHASE1":1401,"PHASE2":1403,"PHASE3":1405,"PHASE4":1417,"NA":1419},{"trials":1400,"activeCount":100},[],{"trials":1402,"activeCount":100},[],{"trials":1404,"activeCount":100},[],{"trials":1406,"activeCount":100},[1407],{"nctId":1408,"briefTitle":1409,"status":298,"phases":1410,"primaryCompletion":1411,"completion":1412,"start":1413,"enrollment":154,"conditions":1414,"interventions":1416},"NCT04447859","16-week Flexible vs. 8-week Semaglutide Titration",[91],"2022-05-10","2022-09-10","2020-02-23",[1415],"Diabetes type2",[1397],{"trials":1418,"activeCount":100},[],{"trials":1420,"activeCount":100},[],{"intervention":1422,"totalTrials":96,"cells":1423},"Cefazolin",{"EARLY_PHASE1":1424,"PHASE1":1426,"PHASE2":1428,"PHASE3":1430,"PHASE4":1442,"NA":1444},{"trials":1425,"activeCount":100},[],{"trials":1427,"activeCount":100},[],{"trials":1429,"activeCount":100},[],{"trials":1431,"activeCount":100},[1432],{"nctId":1433,"briefTitle":1434,"status":298,"phases":1435,"primaryCompletion":1436,"completion":1436,"start":1437,"enrollment":1438,"conditions":1439,"interventions":1441},"NCT02838940","Preventive Antibiotic Serum Levels During Caesarean Section",[91],"2019-08","2016-08",250,[1440],"Blood Antibiotic Levels",[1422],{"trials":1443,"activeCount":100},[],{"trials":1445,"activeCount":100},[],{"intervention":1276,"totalTrials":96,"cells":1447},{"EARLY_PHASE1":1448,"PHASE1":1450,"PHASE2":1452,"PHASE3":1454,"PHASE4":1460,"NA":1462},{"trials":1449,"activeCount":100},[],{"trials":1451,"activeCount":100},[],{"trials":1453,"activeCount":100},[],{"trials":1455,"activeCount":100},[1456],{"nctId":1267,"briefTitle":1268,"status":298,"phases":1457,"primaryCompletion":1270,"completion":1270,"start":1271,"enrollment":1272,"conditions":1458,"interventions":1459},[91],[1274],[1256,1276],{"trials":1461,"activeCount":100},[],{"trials":1463,"activeCount":100},[],{"intervention":1465,"totalTrials":96,"cells":1466},"Adalimumab",{"EARLY_PHASE1":1467,"PHASE1":1469,"PHASE2":1471,"PHASE3":1473,"PHASE4":1483,"NA":1485},{"trials":1468,"activeCount":100},[],{"trials":1470,"activeCount":100},[],{"trials":1472,"activeCount":100},[],{"trials":1474,"activeCount":100},[1475],{"nctId":1476,"briefTitle":1477,"status":298,"phases":1478,"primaryCompletion":910,"completion":910,"start":1479,"enrollment":154,"conditions":1480,"interventions":1481},"NCT01629628","Adalimumab for the Management of Post-operative Crohn's Disease (CD)",[91],"2012-07",[30],[1465,1482],"6 Mercaptopurine",{"trials":1484,"activeCount":100},[],{"trials":1486,"activeCount":100},[],{"intervention":1482,"totalTrials":96,"cells":1488},{"EARLY_PHASE1":1489,"PHASE1":1491,"PHASE2":1493,"PHASE3":1495,"PHASE4":1501,"NA":1503},{"trials":1490,"activeCount":100},[],{"trials":1492,"activeCount":100},[],{"trials":1494,"activeCount":100},[],{"trials":1496,"activeCount":100},[1497],{"nctId":1476,"briefTitle":1477,"status":298,"phases":1498,"primaryCompletion":910,"completion":910,"start":1479,"enrollment":154,"conditions":1499,"interventions":1500},[91],[30],[1465,1482],{"trials":1502,"activeCount":100},[],{"trials":1504,"activeCount":100},[],{"intervention":1506,"totalTrials":96,"cells":1507},"IV Ketamine",{"EARLY_PHASE1":1508,"PHASE1":1510,"PHASE2":1512,"PHASE3":1514,"PHASE4":1527,"NA":1529},{"trials":1509,"activeCount":100},[],{"trials":1511,"activeCount":100},[],{"trials":1513,"activeCount":100},[],{"trials":1515,"activeCount":100},[1516],{"nctId":1517,"briefTitle":1518,"status":298,"phases":1519,"primaryCompletion":1520,"completion":1520,"start":1521,"enrollment":154,"conditions":1522,"interventions":1525},"NCT04013958","Comparison of Treatment by IM Ketamine to IV Ketamine in Patients With Renal Colic",[91],"2021-08-01","2019-08-01",[1523,1524],"Acute Pain","Renal Colic",[1506,1526],"IM Ketamine",{"trials":1528,"activeCount":100},[],{"trials":1530,"activeCount":100},[],{"intervention":1526,"totalTrials":96,"cells":1532},{"EARLY_PHASE1":1533,"PHASE1":1535,"PHASE2":1537,"PHASE3":1539,"PHASE4":1545,"NA":1547},{"trials":1534,"activeCount":100},[],{"trials":1536,"activeCount":100},[],{"trials":1538,"activeCount":100},[],{"trials":1540,"activeCount":100},[1541],{"nctId":1517,"briefTitle":1518,"status":298,"phases":1542,"primaryCompletion":1520,"completion":1520,"start":1521,"enrollment":154,"conditions":1543,"interventions":1544},[91],[1523,1524],[1506,1526],{"trials":1546,"activeCount":100},[],{"trials":1548,"activeCount":100},[],{"intervention":1550,"totalTrials":96,"cells":1551},"Amoxicillin-Potassium Clavulanate Combination",{"EARLY_PHASE1":1552,"PHASE1":1554,"PHASE2":1556,"PHASE3":1558,"PHASE4":1568,"NA":1570},{"trials":1553,"activeCount":100},[],{"trials":1555,"activeCount":100},[],{"trials":1557,"activeCount":100},[],{"trials":1559,"activeCount":100},[1560],{"nctId":1561,"briefTitle":1562,"status":298,"phases":1563,"primaryCompletion":1564,"completion":1564,"start":1271,"enrollment":1438,"conditions":1565,"interventions":1567},"NCT02764710","Randomized Controlled Trial Comparing Long and Short Duration of Antibiotic Prophylaxis for Patients Undergoing Sinus Lift Surgery",[91],"2018-05",[1566],"Maxillofacial Surgery",[1550],{"trials":1569,"activeCount":100},[],{"trials":1571,"activeCount":100},[],{"intervention":1573,"totalTrials":96,"cells":1574},"hCG",{"EARLY_PHASE1":1575,"PHASE1":1577,"PHASE2":1579,"PHASE3":1581,"PHASE4":1592,"NA":1594},{"trials":1576,"activeCount":100},[],{"trials":1578,"activeCount":100},[],{"trials":1580,"activeCount":100},[],{"trials":1582,"activeCount":100},[1583],{"nctId":1584,"briefTitle":1585,"status":298,"phases":1586,"primaryCompletion":1587,"completion":1587,"start":132,"enrollment":1588,"conditions":1589,"interventions":1591},"NCT02862782","Combination of Gonadotropin-releasing Hormone Agonist and Human Chorionic Gonadotropin Triggered by Normal Responder in GnRH-antagonist Cycles",[91],"2019-09",1000,[1590],"In-vitro Fertilization",[1573,1573],{"trials":1593,"activeCount":100},[],{"trials":1595,"activeCount":100},[],{"intervention":1597,"totalTrials":96,"cells":1598},"Erlotinib, Temozolomide",{"EARLY_PHASE1":1599,"PHASE1":1601,"PHASE2":1603,"PHASE3":1605,"PHASE4":1617,"NA":1619},{"trials":1600,"activeCount":100},[],{"trials":1602,"activeCount":100},[],{"trials":1604,"activeCount":100},[],{"trials":1606,"activeCount":100},[1607],{"nctId":1608,"briefTitle":1609,"status":298,"phases":1610,"start":1611,"enrollment":1612,"conditions":1613,"interventions":1616},"NCT00268684","Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLC",[91],"2005-05",381,[1614,1615],"Carcinoma, Non-Small-Cell Lung","Neoplasm Metastasis",[1597],{"trials":1618,"activeCount":100},[],{"trials":1620,"activeCount":100},[],{"intervention":1622,"totalTrials":96,"cells":1623},"Atosiban",{"EARLY_PHASE1":1624,"PHASE1":1626,"PHASE2":1628,"PHASE3":1630,"PHASE4":1643,"NA":1645},{"trials":1625,"activeCount":100},[],{"trials":1627,"activeCount":100},[],{"trials":1629,"activeCount":100},[],{"trials":1631,"activeCount":100},[1632],{"nctId":1633,"briefTitle":1634,"status":298,"phases":1635,"primaryCompletion":1636,"completion":1636,"start":1637,"enrollment":1638,"conditions":1639,"interventions":1641},"NCT02725736","Tocolytic Therapy for Preterm Labor in Multiple Gestation",[91],"2018-03","2016-03",140,[1640],"Labor Preterm Multiple",[1622,1642],"Nifedipine",{"trials":1644,"activeCount":100},[],{"trials":1646,"activeCount":100},[],{"intervention":1642,"totalTrials":96,"cells":1648},{"EARLY_PHASE1":1649,"PHASE1":1651,"PHASE2":1653,"PHASE3":1655,"PHASE4":1661,"NA":1663},{"trials":1650,"activeCount":100},[],{"trials":1652,"activeCount":100},[],{"trials":1654,"activeCount":100},[],{"trials":1656,"activeCount":100},[1657],{"nctId":1633,"briefTitle":1634,"status":298,"phases":1658,"primaryCompletion":1636,"completion":1636,"start":1637,"enrollment":1638,"conditions":1659,"interventions":1660},[91],[1640],[1622,1642],{"trials":1662,"activeCount":100},[],{"trials":1664,"activeCount":100},[],{"intervention":1666,"totalTrials":96,"cells":1667},"12 weeks without Ribavirin",{"EARLY_PHASE1":1668,"PHASE1":1670,"PHASE2":1672,"PHASE3":1674,"PHASE4":1688,"NA":1690},{"trials":1669,"activeCount":100},[],{"trials":1671,"activeCount":100},[],{"trials":1673,"activeCount":100},[],{"trials":1675,"activeCount":100},[1676],{"nctId":1677,"briefTitle":1678,"status":298,"phases":1679,"primaryCompletion":1680,"completion":1681,"start":1682,"enrollment":362,"conditions":1683,"interventions":1685},"NCT02646111","Ombitasvir\u002FParitaprevir\u002FRitonavir and Dasabuvir With and Without Ribavirin in Protease-Inhibitors (\"PI\") Failures",[91],"2018-01","2019-01","2016-01",[1684],"Hepatitis C",[1666,1686,1687],"12 weeks with Ribavirin","24 weeks with Ribavirin",{"trials":1689,"activeCount":100},[],{"trials":1691,"activeCount":100},[],{"intervention":1686,"totalTrials":96,"cells":1693},{"EARLY_PHASE1":1694,"PHASE1":1696,"PHASE2":1698,"PHASE3":1700,"PHASE4":1706,"NA":1708},{"trials":1695,"activeCount":100},[],{"trials":1697,"activeCount":100},[],{"trials":1699,"activeCount":100},[],{"trials":1701,"activeCount":100},[1702],{"nctId":1677,"briefTitle":1678,"status":298,"phases":1703,"primaryCompletion":1680,"completion":1681,"start":1682,"enrollment":362,"conditions":1704,"interventions":1705},[91],[1684],[1666,1686,1687],{"trials":1707,"activeCount":100},[],{"trials":1709,"activeCount":100},[],{"intervention":1687,"totalTrials":96,"cells":1711},{"EARLY_PHASE1":1712,"PHASE1":1714,"PHASE2":1716,"PHASE3":1718,"PHASE4":1724,"NA":1726},{"trials":1713,"activeCount":100},[],{"trials":1715,"activeCount":100},[],{"trials":1717,"activeCount":100},[],{"trials":1719,"activeCount":100},[1720],{"nctId":1677,"briefTitle":1678,"status":298,"phases":1721,"primaryCompletion":1680,"completion":1681,"start":1682,"enrollment":362,"conditions":1722,"interventions":1723},[91],[1684],[1666,1686,1687],{"trials":1725,"activeCount":100},[],{"trials":1727,"activeCount":100},[],{"intervention":1287,"totalTrials":96,"cells":1729},{"EARLY_PHASE1":1730,"PHASE1":1732,"PHASE2":1734,"PHASE3":1736,"PHASE4":1742,"NA":1744},{"trials":1731,"activeCount":100},[],{"trials":1733,"activeCount":100},[],{"trials":1735,"activeCount":100},[],{"trials":1737,"activeCount":100},[1738],{"nctId":1278,"briefTitle":1279,"status":298,"phases":1739,"primaryCompletion":1281,"completion":1281,"start":1282,"enrollment":1283,"conditions":1740,"interventions":1741},[91],[1285],[1287,1256],{"trials":1743,"activeCount":100},[],{"trials":1745,"activeCount":100},[],{"intervention":1311,"totalTrials":96,"cells":1747},{"EARLY_PHASE1":1748,"PHASE1":1750,"PHASE2":1752,"PHASE3":1754,"PHASE4":1760,"NA":1762},{"trials":1749,"activeCount":100},[],{"trials":1751,"activeCount":100},[],{"trials":1753,"activeCount":100},[],{"trials":1755,"activeCount":100},[1756],{"nctId":1304,"briefTitle":1305,"status":298,"phases":1757,"start":1307,"conditions":1758,"interventions":1759},[91],[1309],[1311,1293,1312],{"trials":1761,"activeCount":100},[],{"trials":1763,"activeCount":100},[],{"intervention":1312,"totalTrials":96,"cells":1765},{"EARLY_PHASE1":1766,"PHASE1":1768,"PHASE2":1770,"PHASE3":1772,"PHASE4":1778,"NA":1780},{"trials":1767,"activeCount":100},[],{"trials":1769,"activeCount":100},[],{"trials":1771,"activeCount":100},[],{"trials":1773,"activeCount":100},[1774],{"nctId":1304,"briefTitle":1305,"status":298,"phases":1775,"start":1307,"conditions":1776,"interventions":1777},[91],[1309],[1311,1293,1312],{"trials":1779,"activeCount":100},[],{"trials":1781,"activeCount":100},[],{"intervention":1783,"totalTrials":96,"cells":1784},"ivabradine",{"EARLY_PHASE1":1785,"PHASE1":1787,"PHASE2":1789,"PHASE3":1801,"PHASE4":1803,"NA":1805},{"trials":1786,"activeCount":100},[],{"trials":1788,"activeCount":100},[],{"trials":1790,"activeCount":100},[1791],{"nctId":1792,"briefTitle":1793,"status":298,"phases":1794,"primaryCompletion":1795,"start":1796,"enrollment":1797,"conditions":1798,"interventions":1800},"NCT01761825","The Effect of Ivabradine on Patients With Postural Tachycardia Syndrome",[90],"2013-02","2012-12",20,[1799],"Postural Tachycardia Syndrome",[1783],{"trials":1802,"activeCount":100},[],{"trials":1804,"activeCount":100},[],{"trials":1806,"activeCount":100},[],{"intervention":1808,"totalTrials":96,"cells":1809},"Brinzolamide Ophthalmic",{"EARLY_PHASE1":1810,"PHASE1":1812,"PHASE2":1814,"PHASE3":1826,"PHASE4":1828,"NA":1830},{"trials":1811,"activeCount":100},[],{"trials":1813,"activeCount":100},[],{"trials":1815,"activeCount":100},[1816],{"nctId":1817,"briefTitle":1818,"status":298,"phases":1819,"primaryCompletion":1820,"completion":652,"start":1821,"enrollment":1822,"conditions":1823,"interventions":1825},"NCT03542006","Brinzolamide for the Treatment of Chronic Central Serous Chorioretinopathy",[90],"2019-01-01","2018-06-01",35,[1824],"Central Serous Chorioretinopathy",[1808],{"trials":1827,"activeCount":100},[],{"trials":1829,"activeCount":100},[],{"trials":1831,"activeCount":100},[],{"intervention":1833,"totalTrials":96,"cells":1834},"Eltrombopag",{"EARLY_PHASE1":1835,"PHASE1":1837,"PHASE2":1839,"PHASE3":1852,"PHASE4":1854,"NA":1856},{"trials":1836,"activeCount":100},[],{"trials":1838,"activeCount":100},[],{"trials":1840,"activeCount":100},[1841],{"nctId":1842,"briefTitle":1843,"status":298,"phases":1844,"primaryCompletion":1845,"completion":1846,"start":1847,"enrollment":208,"conditions":1848,"interventions":1851},"NCT05286164","Eltrombopag Treatment in Patients With Prolonged BM Toxicity After CART",[90],"2023-04","2024-04","2022-04",[1849,1850],"CART Treatment","B Cell Lymphoma",[1833],{"trials":1853,"activeCount":100},[],{"trials":1855,"activeCount":100},[],{"trials":1857,"activeCount":100},[],{"intervention":1859,"totalTrials":96,"cells":1860},"Phosphatidylserine-Omega3",{"EARLY_PHASE1":1861,"PHASE1":1863,"PHASE2":1865,"PHASE3":1876,"PHASE4":1878,"NA":1880},{"trials":1862,"activeCount":100},[],{"trials":1864,"activeCount":100},[],{"trials":1866,"activeCount":100},[1867],{"nctId":1868,"briefTitle":1869,"status":396,"phases":1870,"completion":1871,"start":1872,"enrollment":1100,"conditions":1873,"interventions":1875},"NCT00382616","Supplementation of Phosphatidylserine (PS) and n-3 Long Chain Fatty Acids (EPA, DHA) in Children With ADHD",[90],"2005-01","2004-07",[1874],"Attention-Deficit\u002FHyperactivity Disorder",[1859],{"trials":1877,"activeCount":100},[],{"trials":1879,"activeCount":100},[],{"trials":1881,"activeCount":100},[],{"intervention":1883,"totalTrials":96,"cells":1884},"glatiramer acetate",{"EARLY_PHASE1":1885,"PHASE1":1887,"PHASE2":1889,"PHASE3":1900,"PHASE4":1902,"NA":1904},{"trials":1886,"activeCount":100},[],{"trials":1888,"activeCount":100},[],{"trials":1890,"activeCount":100},[1891],{"nctId":1892,"briefTitle":1893,"status":298,"phases":1894,"primaryCompletion":1895,"completion":524,"start":1896,"enrollment":114,"conditions":1897,"interventions":1899},"NCT00731172","A Double Blind Placebo Control Study to Assess the Safety,Tolerability and Efficacy of Copaxone in Crohn's Disease",[90],"2010-07","2008-09",[1898],"Crohns Disease",[1883],{"trials":1901,"activeCount":100},[],{"trials":1903,"activeCount":100},[],{"trials":1905,"activeCount":100},[],{"intervention":1907,"totalTrials":96,"cells":1908},"Eplerenone",{"EARLY_PHASE1":1909,"PHASE1":1911,"PHASE2":1913,"PHASE3":1922,"PHASE4":1924,"NA":1926},{"trials":1910,"activeCount":100},[],{"trials":1912,"activeCount":100},[],{"trials":1914,"activeCount":100},[1915],{"nctId":1916,"briefTitle":1917,"status":298,"phases":1918,"primaryCompletion":756,"start":1919,"enrollment":208,"conditions":1920,"interventions":1921},"NCT02153125","Eplerenone For the Treatment of Chronic Central Serous Chorioretinopathy",[90],"2014-04",[1824],[1907],{"trials":1923,"activeCount":100},[],{"trials":1925,"activeCount":100},[],{"trials":1927,"activeCount":100},[],{"intervention":1929,"totalTrials":96,"cells":1930},"Nivolumab Injection [Opdivo]",{"EARLY_PHASE1":1931,"PHASE1":1933,"PHASE2":1935,"PHASE3":1945,"PHASE4":1947,"NA":1949},{"trials":1932,"activeCount":100},[],{"trials":1934,"activeCount":100},[],{"trials":1936,"activeCount":100},[1937],{"nctId":1938,"briefTitle":1939,"status":298,"phases":1940,"primaryCompletion":1846,"completion":1941,"start":1942,"enrollment":1797,"conditions":1943,"interventions":1944},"NCT05385263","Addition of Nivolumab to Anti-CD-19 CAR-T Cells in Patients With Stable\u002FProgressive DLBCL at Lymphodepletion",[90],"2024-10","2022-05-11",[1850],[1929],{"trials":1946,"activeCount":100},[],{"trials":1948,"activeCount":100},[],{"trials":1950,"activeCount":100},[],{"intervention":1952,"totalTrials":96,"cells":1953},"5ALA",{"EARLY_PHASE1":1954,"PHASE1":1956,"PHASE2":1958,"PHASE3":1969,"PHASE4":1971,"NA":1973},{"trials":1955,"activeCount":100},[],{"trials":1957,"activeCount":100},[],{"trials":1959,"activeCount":100},[1960],{"nctId":1961,"briefTitle":1962,"status":298,"phases":1963,"primaryCompletion":1964,"completion":1965,"start":679,"enrollment":154,"conditions":1966,"interventions":1968},"NCT02050243","The Use of 5-aminolevulinic Acid (ALA) as an Intraoperative Tumor Marker for Resection of Pediatric Central Nervous System (CNS) Tumors",[89,90],"2016-02","2017-02",[1967],"Central Nervous System Tumor, Pediatric",[1952],{"trials":1970,"activeCount":100},[],{"trials":1972,"activeCount":100},[],{"trials":1974,"activeCount":100},[],{"intervention":1976,"totalTrials":96,"cells":1977},"5-Azacytidine and Lenalidomide",{"EARLY_PHASE1":1978,"PHASE1":1980,"PHASE2":1982,"PHASE3":1991,"PHASE4":1993,"NA":1995},{"trials":1979,"activeCount":100},[],{"trials":1981,"activeCount":100},[],{"trials":1983,"activeCount":100},[1984],{"nctId":1985,"briefTitle":1986,"status":298,"phases":1987,"primaryCompletion":1988,"start":588,"enrollment":35,"conditions":1989,"interventions":1990},"NCT01053806","Safety And Efficacy Of Azacitidine, and Lenalidomide In Higher Risk Myelodysplastic Syndrome",[90],"2014-03",[861],[1976],{"trials":1992,"activeCount":100},[],{"trials":1994,"activeCount":100},[],{"trials":1996,"activeCount":100},[],{"intervention":1998,"totalTrials":96,"cells":1999},"Isotretinoin and CO2 laser",{"EARLY_PHASE1":2000,"PHASE1":2002,"PHASE2":2004,"PHASE3":2015,"PHASE4":2017,"NA":2019},{"trials":2001,"activeCount":100},[],{"trials":2003,"activeCount":100},[],{"trials":2005,"activeCount":100},[2006],{"nctId":2007,"briefTitle":2008,"status":298,"phases":2009,"primaryCompletion":2010,"completion":2011,"start":1223,"enrollment":208,"conditions":2012,"interventions":2014},"NCT04870489","Combined Treatment With CO2 Laser and Isotretinoin for Acne Scars",[90],"2020-11-30","2022-06-01",[2013],"Acne Vulgaris",[1998],{"trials":2016,"activeCount":100},[],{"trials":2018,"activeCount":100},[],{"trials":2020,"activeCount":100},[],{"intervention":2022,"totalTrials":96,"cells":2023},"Gentamicin Sulfate",{"EARLY_PHASE1":2024,"PHASE1":2026,"PHASE2":2028,"PHASE3":2038,"PHASE4":2040,"NA":2042},{"trials":2025,"activeCount":100},[],{"trials":2027,"activeCount":100},[],{"trials":2029,"activeCount":100},[2030],{"nctId":2031,"briefTitle":2032,"status":298,"phases":2033,"primaryCompletion":1050,"completion":2034,"start":1281,"enrollment":25,"conditions":2035,"interventions":2037},"NCT03492866","Efficacy of Topical Gentamycin for Hereditary Hypotrichosis Simplex Caused by Nonsense Mutations in CDSN",[90],"2019-04",[2036],"Hereditary Hypotrichosis Simplex",[2022],{"trials":2039,"activeCount":100},[],{"trials":2041,"activeCount":100},[],{"trials":2043,"activeCount":100},[],{"intervention":2045,"totalTrials":96,"cells":2046},"platelets",{"EARLY_PHASE1":2047,"PHASE1":2049,"PHASE2":2051,"PHASE3":2065,"PHASE4":2067,"NA":2069},{"trials":2048,"activeCount":100},[],{"trials":2050,"activeCount":100},[],{"trials":2052,"activeCount":100},[2053],{"nctId":2054,"briefTitle":2055,"status":298,"phases":2056,"primaryCompletion":587,"completion":2057,"start":2058,"enrollment":154,"conditions":2059,"interventions":2064},"NCT01135862","Platelet Administration To Patients With Traumatic Brain Injury Who Were Treated With Aspirin",[90],"2013-06","2010-06",[2060,2061,2062,2063],"Aspirin Treatment","Traumatic Intracranial Bleed","Hemorrhage Growth","Neurological Outcome",[2045],{"trials":2066,"activeCount":100},[],{"trials":2068,"activeCount":100},[],{"trials":2070,"activeCount":100},[],{"intervention":2072,"totalTrials":96,"cells":2073},"Topical Benzocaine",{"EARLY_PHASE1":2074,"PHASE1":2076,"PHASE2":2078,"PHASE3":2093,"PHASE4":2095,"NA":2097},{"trials":2075,"activeCount":100},[],{"trials":2077,"activeCount":100},[],{"trials":2079,"activeCount":100},[2080],{"nctId":2081,"briefTitle":2082,"status":2083,"phases":2084,"primaryCompletion":2085,"completion":2085,"start":2086,"enrollment":2087,"conditions":2088,"interventions":2092},"NCT01274247","Use of Topical Benzocaine for Analgesia in Lingual Frenotomy of the Newborn","TERMINATED",[89,90],"2012-06","2011-02",21,[2089,2090,2091],"Neonatal Tongue-tie","Maternal Nipple Pain Upon Breastfeeding","Neonatal Latch Difficulties",[2072],{"trials":2094,"activeCount":100},[],{"trials":2096,"activeCount":100},[],{"trials":2098,"activeCount":100},[],{"intervention":2100,"totalTrials":96,"cells":2101},"Vivomixx",{"EARLY_PHASE1":2102,"PHASE1":2104,"PHASE2":2106,"PHASE3":2118,"PHASE4":2120,"NA":2122},{"trials":2103,"activeCount":100},[],{"trials":2105,"activeCount":100},[],{"trials":2107,"activeCount":100},[2108],{"nctId":2109,"briefTitle":2110,"status":298,"phases":2111,"primaryCompletion":2112,"completion":2113,"start":1681,"enrollment":8,"conditions":2114,"interventions":2117},"NCT03518268","Vivomixx for Prevention of Bone Loss in Women With Breast Cancer Treated With an Aromatase Inhibitor",[89,90],"2021-04","2021-06",[2115,2116],"Breast Cancer","Osteoporosis, Osteopenia",[2100],{"trials":2119,"activeCount":100},[],{"trials":2121,"activeCount":100},[],{"trials":2123,"activeCount":100},[],{"intervention":2125,"totalTrials":96,"cells":2126},"Maraviroc 300 mg",{"EARLY_PHASE1":2127,"PHASE1":2129,"PHASE2":2131,"PHASE3":2142,"PHASE4":2144,"NA":2146},{"trials":2128,"activeCount":100},[],{"trials":2130,"activeCount":100},[],{"trials":2132,"activeCount":100},[2133],{"nctId":2134,"briefTitle":2135,"status":396,"phases":2136,"primaryCompletion":2137,"completion":2137,"start":2138,"enrollment":19,"conditions":2139,"interventions":2141},"NCT05932550","Safety of Maraviroc for Post-stroke Depression",[90],"2022-08-04","2020-08-04",[2140],"Post-stroke Depression",[2125],{"trials":2143,"activeCount":100},[],{"trials":2145,"activeCount":100},[],{"trials":2147,"activeCount":100},[],{"intervention":2149,"totalTrials":96,"cells":2150},"Fenugreek seed meal",{"EARLY_PHASE1":2151,"PHASE1":2153,"PHASE2":2155,"PHASE3":2167,"PHASE4":2169,"NA":2171},{"trials":2152,"activeCount":100},[],{"trials":2154,"activeCount":100},[],{"trials":2156,"activeCount":100},[2157],{"nctId":2158,"briefTitle":2159,"status":298,"phases":2160,"primaryCompletion":2113,"completion":2161,"start":2162,"enrollment":208,"conditions":2163,"interventions":2166},"NCT02384655","Effect of Fenugreek Use in Mothers of Preterm on Breast Milk Production and Macronutrient Content",[89,90],"2021-09","2015-03-11",[2164,2165],"Preterms","Lactation",[2149],{"trials":2168,"activeCount":100},[],{"trials":2170,"activeCount":100},[],{"trials":2172,"activeCount":100},[],{"intervention":2174,"totalTrials":96,"cells":2175},"5-aza-cytidine and Thalidomide",{"EARLY_PHASE1":2176,"PHASE1":2178,"PHASE2":2180,"PHASE3":2190,"PHASE4":2192,"NA":2194},{"trials":2177,"activeCount":100},[],{"trials":2179,"activeCount":100},[],{"trials":2181,"activeCount":100},[2182],{"nctId":2183,"briefTitle":2184,"status":298,"phases":2185,"primaryCompletion":2186,"completion":2187,"start":1896,"enrollment":114,"conditions":2188,"interventions":2189},"NCT00704704","Safety and Efficacy of Azacitidine, and Thalidomide in Higher Risk MDS (Myelodysplastic Syndrome)",[90],"2010-09","2011-04",[861],[2174],{"trials":2191,"activeCount":100},[],{"trials":2193,"activeCount":100},[],{"trials":2195,"activeCount":100},[],{"intervention":2197,"totalTrials":96,"cells":2198},"Ranolazine",{"EARLY_PHASE1":2199,"PHASE1":2201,"PHASE2":2203,"PHASE3":2214,"PHASE4":2216,"NA":2218},{"trials":2200,"activeCount":100},[],{"trials":2202,"activeCount":100},[],{"trials":2204,"activeCount":100},[2205],{"nctId":2206,"briefTitle":2207,"status":298,"phases":2208,"primaryCompletion":2209,"completion":2209,"start":2210,"enrollment":19,"conditions":2211,"interventions":2213},"NCT01728025","Long Term Prophylactic Therapy of Congenital Long QT Syndrome Type III (LQT3) With Ranolazine",[90],"2017-11","2012-10",[2212],"Long QT Syndrome Type 3",[2197],{"trials":2215,"activeCount":100},[],{"trials":2217,"activeCount":100},[],{"trials":2219,"activeCount":100},[],{"intervention":2221,"totalTrials":96,"cells":2222},"Fecal Microbiota Transplantation",{"EARLY_PHASE1":2223,"PHASE1":2225,"PHASE2":2227,"PHASE3":2235,"PHASE4":2237,"NA":2239},{"trials":2224,"activeCount":100},[],{"trials":2226,"activeCount":100},[],{"trials":2228,"activeCount":100},[2229],{"nctId":2230,"briefTitle":2231,"status":298,"phases":2232,"primaryCompletion":1680,"start":1282,"enrollment":208,"conditions":2233,"interventions":2234},"NCT02346669","Fecal Microbiota Transplantation for Diabetes Mellitus Type II in Obese Patients",[90],[886,24],[2221],{"trials":2236,"activeCount":100},[],{"trials":2238,"activeCount":100},[],{"trials":2240,"activeCount":100},[],{"intervention":2242,"totalTrials":96,"cells":2243},"Diacerin cream",{"EARLY_PHASE1":2244,"PHASE1":2246,"PHASE2":2248,"PHASE3":2258,"PHASE4":2260,"NA":2262},{"trials":2245,"activeCount":100},[],{"trials":2247,"activeCount":100},[],{"trials":2249,"activeCount":100},[2250],{"nctId":2251,"briefTitle":2252,"status":298,"phases":2253,"primaryCompletion":2254,"start":756,"enrollment":114,"conditions":2255,"interventions":2257},"NCT02470689","Diacerin for the Treatment of Epidermolysis Bullosa Simplex",[90],"2017-12",[2256],"Epidermolysis Bullosa Simplex",[2242],{"trials":2259,"activeCount":100},[],{"trials":2261,"activeCount":100},[],{"trials":2263,"activeCount":100},[],{"intervention":2265,"totalTrials":96,"cells":2266},"Maraviroc",{"EARLY_PHASE1":2267,"PHASE1":2269,"PHASE2":2271,"PHASE3":2283,"PHASE4":2285,"NA":2287},{"trials":2268,"activeCount":100},[],{"trials":2270,"activeCount":100},[],{"trials":2272,"activeCount":100},[2273],{"nctId":2274,"briefTitle":2275,"status":298,"phases":2276,"primaryCompletion":1846,"completion":2277,"start":2278,"enrollment":2279,"conditions":2280,"interventions":2282},"NCT04966429","Safety and Efficacy of Maraviroc in Post-stroke Cognitive Impairment",[90],"2024-06","2021-05-01",150,[2281],"Post Stroke Cognitive Impairment",[2265],{"trials":2284,"activeCount":100},[],{"trials":2286,"activeCount":100},[],{"trials":2288,"activeCount":100},[],{"intervention":2290,"totalTrials":96,"cells":2291},"Human growth hormone,ZOMACTON®",{"EARLY_PHASE1":2292,"PHASE1":2294,"PHASE2":2296,"PHASE3":2308,"PHASE4":2310,"NA":2312},{"trials":2293,"activeCount":100},[],{"trials":2295,"activeCount":100},[],{"trials":2297,"activeCount":100},[2298],{"nctId":2299,"briefTitle":2300,"status":298,"phases":2301,"primaryCompletion":2254,"completion":538,"start":2302,"enrollment":1797,"conditions":2303,"interventions":2307},"NCT02326610","Early hGH Treatment of SGA Infants to Prevent Irreversible Neurologic and Psychological Damage and Sequelae",[90],"2014-12",[2304,2305,2306],"Infant, Small for Gestational Age","Growth Hormone Treatment","Infant, Premature, Diseases",[2290],{"trials":2309,"activeCount":100},[],{"trials":2311,"activeCount":100},[],{"trials":2313,"activeCount":100},[],{"intervention":2315,"totalTrials":96,"cells":2316},"Carfilzomib",{"EARLY_PHASE1":2317,"PHASE1":2319,"PHASE2":2321,"PHASE3":2340,"PHASE4":2342,"NA":2344},{"trials":2318,"activeCount":100},[],{"trials":2320,"activeCount":100},[],{"trials":2322,"activeCount":100},[2323],{"nctId":2324,"briefTitle":2325,"status":396,"phases":2326,"primaryCompletion":2327,"completion":2328,"start":2329,"enrollment":2330,"conditions":2331,"interventions":2336},"NCT04065789","Carfilzomib in Combination With Daratumumab, Lenalidomide and Dexamethasone in Transplant-ineligible NDMM Patients",[90],"2021-08-27","2021-11-12","2018-05-02",41,[2332,2333,2334,2335],"Myeloma Multiple","Myeloma, Plasma-Cell","Myeloma-Multiple","Plasma Cell Myeloma",[2315,2337,2338,2339],"Daratumumab","Lenalidomide","Dexamethasone",{"trials":2341,"activeCount":100},[],{"trials":2343,"activeCount":100},[],{"trials":2345,"activeCount":100},[],{"intervention":2337,"totalTrials":96,"cells":2347},{"EARLY_PHASE1":2348,"PHASE1":2350,"PHASE2":2352,"PHASE3":2358,"PHASE4":2360,"NA":2362},{"trials":2349,"activeCount":100},[],{"trials":2351,"activeCount":100},[],{"trials":2353,"activeCount":100},[2354],{"nctId":2324,"briefTitle":2325,"status":396,"phases":2355,"primaryCompletion":2327,"completion":2328,"start":2329,"enrollment":2330,"conditions":2356,"interventions":2357},[90],[2332,2333,2334,2335],[2315,2337,2338,2339],{"trials":2359,"activeCount":100},[],{"trials":2361,"activeCount":100},[],{"trials":2363,"activeCount":100},[],{"intervention":2338,"totalTrials":96,"cells":2365},{"EARLY_PHASE1":2366,"PHASE1":2368,"PHASE2":2370,"PHASE3":2376,"PHASE4":2378,"NA":2380},{"trials":2367,"activeCount":100},[],{"trials":2369,"activeCount":100},[],{"trials":2371,"activeCount":100},[2372],{"nctId":2324,"briefTitle":2325,"status":396,"phases":2373,"primaryCompletion":2327,"completion":2328,"start":2329,"enrollment":2330,"conditions":2374,"interventions":2375},[90],[2332,2333,2334,2335],[2315,2337,2338,2339],{"trials":2377,"activeCount":100},[],{"trials":2379,"activeCount":100},[],{"trials":2381,"activeCount":100},[],{"intervention":2339,"totalTrials":96,"cells":2383},{"EARLY_PHASE1":2384,"PHASE1":2386,"PHASE2":2388,"PHASE3":2394,"PHASE4":2396,"NA":2398},{"trials":2385,"activeCount":100},[],{"trials":2387,"activeCount":100},[],{"trials":2389,"activeCount":100},[2390],{"nctId":2324,"briefTitle":2325,"status":396,"phases":2391,"primaryCompletion":2327,"completion":2328,"start":2329,"enrollment":2330,"conditions":2392,"interventions":2393},[90],[2332,2333,2334,2335],[2315,2337,2338,2339],{"trials":2395,"activeCount":100},[],{"trials":2397,"activeCount":100},[],{"trials":2399,"activeCount":100},[],{"intervention":2401,"totalTrials":96,"cells":2402},"Fecal Microbiota",{"EARLY_PHASE1":2403,"PHASE1":2405,"PHASE2":2407,"PHASE3":2416,"PHASE4":2418,"NA":2420},{"trials":2404,"activeCount":100},[],{"trials":2406,"activeCount":100},[],{"trials":2408,"activeCount":100},[2409],{"nctId":2410,"briefTitle":2411,"status":2083,"phases":2412,"primaryCompletion":910,"completion":910,"start":2413,"enrollment":539,"conditions":2414,"interventions":2415},"NCT04434872","Fecal Microbiota Transplantation as a Treatment for Ulcerative Colitis",[90],"2015-07",[32],[2401],{"trials":2417,"activeCount":100},[],{"trials":2419,"activeCount":100},[],{"trials":2421,"activeCount":100},[],{"intervention":2423,"totalTrials":96,"cells":2424},"EXO-CD24",{"EARLY_PHASE1":2425,"PHASE1":2427,"PHASE2":2438,"PHASE3":2440,"PHASE4":2442,"NA":2444},{"trials":2426,"activeCount":100},[],{"trials":2428,"activeCount":100},[2429],{"nctId":2430,"briefTitle":2431,"status":298,"phases":2432,"primaryCompletion":2433,"completion":180,"start":2434,"enrollment":1822,"conditions":2435,"interventions":2437},"NCT04747574","Evaluation of the Safety of CD24-Exosomes in Patients With COVID-19 Infection",[89],"2021-02-25","2020-09-25",[2436],"SARS-CoV-2",[2423],{"trials":2439,"activeCount":100},[],{"trials":2441,"activeCount":100},[],{"trials":2443,"activeCount":100},[],{"trials":2445,"activeCount":100},[],{"intervention":2447,"totalTrials":96,"cells":2448},"cyclosporine in combination with carfilzomib and dexamethasone",{"EARLY_PHASE1":2449,"PHASE1":2451,"PHASE2":2462,"PHASE3":2464,"PHASE4":2466,"NA":2468},{"trials":2450,"activeCount":100},[],{"trials":2452,"activeCount":100},[2453],{"nctId":2454,"briefTitle":2455,"status":396,"phases":2456,"primaryCompletion":2457,"completion":2457,"start":2458,"enrollment":281,"conditions":2459,"interventions":2461},"NCT04813653","Cyclosporine in Combination With Carfilzomib and Dexamethasone in Relapsed Multiple Myeloma Refractory to Carfilzomib and High Expression of PPIA Gene in Myeloma Cells",[89],"2025-03-05","2021-04-18",[183,2460],"Multiple Myeloma, Refractory",[2447],{"trials":2463,"activeCount":100},[],{"trials":2465,"activeCount":100},[],{"trials":2467,"activeCount":100},[],{"trials":2469,"activeCount":100},[],{"intervention":2471,"totalTrials":96,"cells":2472},"prostaglandins E2",{"EARLY_PHASE1":2473,"PHASE1":2487,"PHASE2":2489,"PHASE3":2491,"PHASE4":2493,"NA":2495},{"trials":2474,"activeCount":100},[2475],{"nctId":2476,"briefTitle":2477,"status":298,"phases":2478,"primaryCompletion":2479,"completion":2480,"start":2481,"enrollment":2482,"conditions":2483,"interventions":2486},"NCT03625518","Mode of Induction in Fetal Growth Restriction and Its Affects on Fetal and Maternal Outcomes",[88],"2020-07","2021-01","2018-09",280,[2484,2485],"Fetal Growth Retardation","Induction of Labor Affected Fetus \u002F Newborn",[2471],{"trials":2488,"activeCount":100},[],{"trials":2490,"activeCount":100},[],{"trials":2492,"activeCount":100},[],{"trials":2494,"activeCount":100},[],{"trials":2496,"activeCount":100},[],{"intervention":2498,"totalTrials":96,"cells":2499},"Intrathecal methotrexate",{"EARLY_PHASE1":2500,"PHASE1":2509,"PHASE2":2511,"PHASE3":2513,"PHASE4":2515,"NA":2517},{"trials":2501,"activeCount":100},[2502],{"nctId":2503,"briefTitle":2504,"status":298,"phases":2505,"primaryCompletion":2254,"completion":1680,"start":1682,"enrollment":208,"conditions":2506,"interventions":2508},"NCT02644044","Intrathecal Methotrexate for Progressive Multiple Sclerosis: An Open Label Single Arm Study",[88],[2507],"To Evaluate the Effect of Therapy With IT MTX on the Disease Course of Patients With Progressive MS",[2498],{"trials":2510,"activeCount":100},[],{"trials":2512,"activeCount":100},[],{"trials":2514,"activeCount":100},[],{"trials":2516,"activeCount":100},[],{"trials":2518,"activeCount":100},[],{"intervention":2520,"totalTrials":96,"cells":2521},"Oxygen",{"EARLY_PHASE1":2522,"PHASE1":2533,"PHASE2":2535,"PHASE3":2537,"PHASE4":2539,"NA":2541},{"trials":2523,"activeCount":100},[2524],{"nctId":2525,"briefTitle":2526,"status":298,"phases":2527,"primaryCompletion":909,"start":2528,"enrollment":1797,"conditions":2529,"interventions":2531},"NCT02246517","The Effect of N2O on Chronic Neuropathic Pain Patients",[88],"2014-09",[2530],"Neuropathic Pain",[2532,2520],"N2O",{"trials":2534,"activeCount":100},[],{"trials":2536,"activeCount":100},[],{"trials":2538,"activeCount":100},[],{"trials":2540,"activeCount":100},[],{"trials":2542,"activeCount":100},[],{"intervention":307,"totalTrials":28,"cells":2544},{"EARLY_PHASE1":2545,"PHASE1":2547,"PHASE2":2549,"PHASE3":2562,"PHASE4":2572,"NA":2582},{"trials":2546,"activeCount":100},[],{"trials":2548,"activeCount":100},[],{"trials":2550,"activeCount":100},[2551],{"nctId":2552,"briefTitle":2553,"status":298,"phases":2554,"primaryCompletion":2555,"completion":2556,"start":2557,"enrollment":208,"conditions":2558,"interventions":2560},"NCT04242914","The Effect of Intravenous Ketamine on Non Suicidal Self Injuries.",[89,90],"2021-02-24","2024-02-24","2019-02-25",[2559],"Non Suicidal Self Injury",[307,2561],"Midazolam",{"trials":2563,"activeCount":100},[2564,2568],{"nctId":357,"briefTitle":358,"status":298,"phases":2565,"primaryCompletion":360,"completion":360,"start":361,"enrollment":362,"conditions":2566,"interventions":2567},[91],[364],[41,307],{"nctId":296,"briefTitle":297,"status":298,"phases":2569,"primaryCompletion":300,"completion":300,"start":301,"enrollment":154,"conditions":2570,"interventions":2571},[91],[303,304,305],[307,161],{"trials":2573,"activeCount":100},[2574,2578],{"nctId":949,"briefTitle":950,"status":298,"phases":2575,"primaryCompletion":952,"completion":953,"start":954,"enrollment":955,"conditions":2576,"interventions":2577},[92],[957],[959,960,936],{"nctId":1206,"briefTitle":1207,"status":298,"phases":2579,"primaryCompletion":952,"completion":953,"start":954,"enrollment":955,"conditions":2580,"interventions":2581},[92],[1010],[959,960,1193],{"trials":2583,"activeCount":100},[2584,2596],{"nctId":2585,"briefTitle":2586,"status":298,"phases":2587,"primaryCompletion":2588,"completion":2589,"start":2590,"enrollment":1100,"conditions":2591,"interventions":2594},"NCT03041506","Interscalene Nerve Block vs. Sedation for Shoulder Dislocation Reduction",[93],"2017-12-31","2018-12-31","2017-02-15",[2592,2593],"Shoulder Dislocation","Brachial Plexus Block",[2595,2561,307],"Lidocaine",{"nctId":2597,"briefTitle":2598,"status":396,"phases":2599,"primaryCompletion":2600,"completion":2600,"start":2601,"enrollment":362,"conditions":2602,"interventions":2604},"NCT01070108","Escalating Ketamine Doses and Pre-emption",[93],"2009-01","2007-01",[2603],"Postoperative Pain Management",[307,960,960],{"intervention":2606,"totalTrials":2607,"cells":2608},"Pregabalin",5,{"EARLY_PHASE1":2609,"PHASE1":2611,"PHASE2":2613,"PHASE3":2615,"PHASE4":2617,"NA":2619},{"trials":2610,"activeCount":100},[],{"trials":2612,"activeCount":100},[],{"trials":2614,"activeCount":100},[],{"trials":2616,"activeCount":100},[],{"trials":2618,"activeCount":100},[],{"trials":2620,"activeCount":100},[2621,2631,2638,2644,2651],{"nctId":2622,"briefTitle":2623,"status":298,"phases":2624,"primaryCompletion":1367,"start":1479,"enrollment":154,"conditions":2625,"interventions":2628},"NCT01614236","Pre- Versus Post-Incisional Pregabalin for Postoperative Pain Control",[93],[2626,2627],"Postoperative Pain Control","Multimodal Analgesia",[2629,2630],"pregabalin","epidural",{"nctId":2632,"briefTitle":2633,"status":298,"phases":2634,"primaryCompletion":2057,"start":2085,"enrollment":154,"conditions":2635,"interventions":2637},"NCT01612832","Pregabalin for Post-craniotomy Pain Control",[93],[2636],"To Assess the Beneficial Preemptive and Preventive Effects of PGL on the Immediate and Late (1- and 3 Months) Postoperative Analgesia Requirements",[2606],{"nctId":2639,"briefTitle":2640,"status":298,"phases":2641,"primaryCompletion":2057,"completion":2057,"start":587,"enrollment":539,"conditions":2642,"interventions":2643},"NCT01359059","Pre- Versus Post-incisional Pregabalin for Postoperative Pain Attenuation and Analgesics Spare in Orthopedic Oncologic Patients",[93],[1010],[2606,2606],{"nctId":2645,"briefTitle":2646,"status":298,"phases":2647,"primaryCompletion":2085,"start":587,"enrollment":2648,"conditions":2649,"interventions":2650},"NCT01359085","Pain Relief Following Arthroscopic Rotator Cuff Repair: Perioperative Pregabalin Administration Versus Interscalene Brachial Plexus Block",[93],56,[15],[2606],{"nctId":2652,"briefTitle":2653,"status":298,"phases":2654,"primaryCompletion":373,"completion":373,"start":317,"enrollment":2279,"conditions":2655,"interventions":2657},"NCT01268631","Mechanism-based Choice of Therapy: Can Treatments Success in Fibromyalgia Patients be Coupled to Psychophysical Pain Modulation Profile?",[93],[2656],"Fibromyalgia",[2658,2606],"Duloxetine",{"intervention":2660,"totalTrials":281,"cells":2661},"Escitalopram",{"EARLY_PHASE1":2662,"PHASE1":2664,"PHASE2":2666,"PHASE3":2668,"PHASE4":2678,"NA":2680},{"trials":2663,"activeCount":100},[],{"trials":2665,"activeCount":100},[],{"trials":2667,"activeCount":100},[],{"trials":2669,"activeCount":100},[2670],{"nctId":2671,"briefTitle":2672,"status":298,"phases":2673,"primaryCompletion":2254,"completion":2254,"start":909,"enrollment":154,"conditions":2674,"interventions":2677},"NCT02623231","The Effect of Escitalopram on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients",[90,91],[2675,2676],"GBM","Depression",[2660],{"trials":2679,"activeCount":100},[],{"trials":2681,"activeCount":100},[2682,2691],{"nctId":2683,"briefTitle":2684,"status":298,"phases":2685,"primaryCompletion":2686,"completion":2686,"start":2687,"enrollment":8,"conditions":2688,"interventions":2690},"NCT00598052","Treatment of Marijuana Withdrawal Syndrome Using Escitalopram and Cognitive-Behavior Therapy",[93],"2008-10","2007-12",[2689],"Marijuana Dependence",[2660],{"nctId":2692,"briefTitle":2693,"status":298,"phases":2694,"primaryCompletion":316,"completion":316,"start":2695,"enrollment":362,"conditions":2696,"interventions":2699},"NCT00989053","The Effect of Selective Serotonin Reuptake Inhibitor (SSRI) Treatment on Affective Symptoms and Fertility Treatment Outcome in Women Undergoing in Vitro Fertilization (IVF)",[93],"2010-01",[2676,2697,2698],"Anxiety","In Vitro Fertilization",[2700],"escitalopram",{"intervention":959,"totalTrials":281,"cells":2702},{"EARLY_PHASE1":2703,"PHASE1":2705,"PHASE2":2707,"PHASE3":2709,"PHASE4":2711,"NA":2721},{"trials":2704,"activeCount":100},[],{"trials":2706,"activeCount":100},[],{"trials":2708,"activeCount":100},[],{"trials":2710,"activeCount":100},[],{"trials":2712,"activeCount":100},[2713,2717],{"nctId":949,"briefTitle":950,"status":298,"phases":2714,"primaryCompletion":952,"completion":953,"start":954,"enrollment":955,"conditions":2715,"interventions":2716},[92],[957],[959,960,936],{"nctId":1206,"briefTitle":1207,"status":298,"phases":2718,"primaryCompletion":952,"completion":953,"start":954,"enrollment":955,"conditions":2719,"interventions":2720},[92],[1010],[959,960,1193],{"trials":2722,"activeCount":100},[2723],{"nctId":2585,"briefTitle":2586,"status":298,"phases":2724,"primaryCompletion":2588,"completion":2589,"start":2590,"enrollment":1100,"conditions":2725,"interventions":2726},[93],[2592,2593],[2595,2561,307],{"intervention":2561,"totalTrials":281,"cells":2728},{"EARLY_PHASE1":2729,"PHASE1":2731,"PHASE2":2733,"PHASE3":2746,"PHASE4":2748,"NA":2750},{"trials":2730,"activeCount":100},[],{"trials":2732,"activeCount":100},[],{"trials":2734,"activeCount":100},[2735,2739],{"nctId":2552,"briefTitle":2553,"status":298,"phases":2736,"primaryCompletion":2555,"completion":2556,"start":2557,"enrollment":208,"conditions":2737,"interventions":2738},[89,90],[2559],[307,2561],{"nctId":2740,"briefTitle":2741,"status":298,"phases":2742,"primaryCompletion":679,"completion":679,"start":1074,"enrollment":154,"conditions":2743,"interventions":2745},"NCT01503788","Bedside Sedation for the Prevention of Post Dural Puncture Headache",[90],[2744],"Post Dural Puncture Headache",[2561],{"trials":2747,"activeCount":100},[],{"trials":2749,"activeCount":100},[],{"trials":2751,"activeCount":100},[2752],{"nctId":2585,"briefTitle":2586,"status":298,"phases":2753,"primaryCompletion":2588,"completion":2589,"start":2590,"enrollment":1100,"conditions":2754,"interventions":2755},[93],[2592,2593],[2595,2561,307],{"intervention":567,"totalTrials":512,"cells":2757},{"EARLY_PHASE1":2758,"PHASE1":2760,"PHASE2":2762,"PHASE3":2764,"PHASE4":2766,"NA":2772},{"trials":2759,"activeCount":100},[],{"trials":2761,"activeCount":100},[],{"trials":2763,"activeCount":100},[],{"trials":2765,"activeCount":100},[],{"trials":2767,"activeCount":100},[2768],{"nctId":559,"briefTitle":560,"status":396,"phases":2769,"primaryCompletion":562,"completion":562,"start":563,"enrollment":229,"conditions":2770,"interventions":2771},[92],[565],[546,567],{"trials":2773,"activeCount":100},[2774],{"nctId":2775,"briefTitle":2776,"status":298,"phases":2777,"primaryCompletion":909,"completion":2778,"start":2779,"enrollment":1797,"conditions":2780,"interventions":2781},"NCT02253758","Arousal Pathways and Emergence From Sedation",[93],"2016-12","2014-10",[389],[567],{"intervention":2783,"totalTrials":512,"cells":2784},"Influenza vaccine",{"EARLY_PHASE1":2785,"PHASE1":2787,"PHASE2":2789,"PHASE3":2791,"PHASE4":2793,"NA":2802},{"trials":2786,"activeCount":100},[],{"trials":2788,"activeCount":100},[],{"trials":2790,"activeCount":100},[],{"trials":2792,"activeCount":100},[],{"trials":2794,"activeCount":100},[2795],{"nctId":2796,"briefTitle":2797,"status":298,"phases":2798,"primaryCompletion":1097,"completion":1097,"start":525,"enrollment":539,"conditions":2799,"interventions":2801},"NCT01002508","Influenza Vaccination in Patients With Scleroderma",[92],[2800],"Influenza Vaccine in Scleroderma",[2783],{"trials":2803,"activeCount":100},[2804],{"nctId":2805,"briefTitle":2806,"status":2083,"phases":2807,"completion":2808,"start":2809,"enrollment":440,"conditions":2810,"interventions":2811},"NCT00466037","The Effect of Rituximab on the Humoral Response to Influenza Vaccine",[93],"2006-02","2005-09",[541],[2783],{"intervention":2630,"totalTrials":512,"cells":2813},{"EARLY_PHASE1":2814,"PHASE1":2816,"PHASE2":2818,"PHASE3":2820,"PHASE4":2830,"NA":2832},{"trials":2815,"activeCount":100},[],{"trials":2817,"activeCount":100},[],{"trials":2819,"activeCount":100},[],{"trials":2821,"activeCount":100},[2822],{"nctId":2823,"briefTitle":2824,"status":298,"phases":2825,"primaryCompletion":2826,"start":1637,"enrollment":8,"conditions":2827,"interventions":2829},"NCT02725723","Thermographic Images as an Objective Method for Assessing the Efficacy of Steroidal Epidural Injections",[90,91],"2017-03",[2828],"Spinal Stenosis",[2630],{"trials":2831,"activeCount":100},[],{"trials":2833,"activeCount":100},[2834],{"nctId":2622,"briefTitle":2623,"status":298,"phases":2835,"primaryCompletion":1367,"start":1479,"enrollment":154,"conditions":2836,"interventions":2837},[93],[2626,2627],[2629,2630],{"intervention":2839,"totalTrials":512,"cells":2840},"Focetria",{"EARLY_PHASE1":2841,"PHASE1":2843,"PHASE2":2845,"PHASE3":2856,"PHASE4":2858,"NA":2860},{"trials":2842,"activeCount":100},[],{"trials":2844,"activeCount":100},[],{"trials":2846,"activeCount":100},[2847],{"nctId":2848,"briefTitle":2849,"status":298,"phases":2850,"primaryCompletion":1098,"completion":1098,"start":525,"enrollment":2851,"conditions":2852,"interventions":2855},"NCT01006681","Vaccination Against Influenza H1N1 in Rheumatic Diseases",[90],400,[2853,2854],"Influenza","Rheumatic Diseases",[2839,2839,2839],{"trials":2857,"activeCount":100},[],{"trials":2859,"activeCount":100},[],{"trials":2861,"activeCount":100},[2862],{"nctId":2863,"briefTitle":2864,"status":298,"phases":2865,"primaryCompletion":525,"completion":1098,"start":525,"enrollment":375,"conditions":2866,"interventions":2868},"NCT01019837","Efficacy and Safety of Vaccination Against Influenza H1N1 in Patients With Inflammatory Bowel Diseases (IBD) Treated Immunomodulators and Biologics",[93],[2867],"Influenza H1N1",[2839],{"intervention":2870,"totalTrials":512,"cells":2871},"Risperidone",{"EARLY_PHASE1":2872,"PHASE1":2874,"PHASE2":2876,"PHASE3":2878,"PHASE4":2880,"NA":2882},{"trials":2873,"activeCount":100},[],{"trials":2875,"activeCount":100},[],{"trials":2877,"activeCount":100},[],{"trials":2879,"activeCount":100},[],{"trials":2881,"activeCount":100},[],{"trials":2883,"activeCount":100},[2884,2893],{"nctId":2885,"briefTitle":2886,"status":298,"phases":2887,"primaryCompletion":2888,"start":2889,"enrollment":208,"conditions":2890,"interventions":2892},"NCT00633802","Low-Dose Risperidone Treatment for Subjects Suffering From Borderline Personality Disorder",[93],"2009-04","2004-04",[2891],"Borderlone Personality Disorder",[2870],{"nctId":2894,"briefTitle":2895,"status":298,"phases":2896,"primaryCompletion":2897,"completion":680,"start":316,"enrollment":154,"conditions":2898,"interventions":2901},"NCT01510015","Evaluation of the Effects of Treatment of Psycho-stimulant and Cannabis-dependent Users in Israel",[93],"2013-10",[2899,2900],"Cannabis Dependence","Psychostimulant Dependence",[2870],{"intervention":2532,"totalTrials":512,"cells":2903},{"EARLY_PHASE1":2904,"PHASE1":2910,"PHASE2":2912,"PHASE3":2914,"PHASE4":2916,"NA":2918},{"trials":2905,"activeCount":100},[2906],{"nctId":2525,"briefTitle":2526,"status":298,"phases":2907,"primaryCompletion":909,"start":2528,"enrollment":1797,"conditions":2908,"interventions":2909},[88],[2530],[2532,2520],{"trials":2911,"activeCount":100},[],{"trials":2913,"activeCount":100},[],{"trials":2915,"activeCount":100},[],{"trials":2917,"activeCount":100},[],{"trials":2919,"activeCount":100},[2920],{"nctId":2921,"briefTitle":2922,"status":298,"phases":2923,"primaryCompletion":2924,"completion":1437,"start":2779,"enrollment":19,"conditions":2925,"interventions":2926},"NCT01616004","Effect of Acute Treatment With N2O on Inhibitory Pain Mechanisms in Healthy Subject",[93],"2015-08",[15],[2532,2927],"Air",{"intervention":1322,"totalTrials":512,"cells":2929},{"EARLY_PHASE1":2930,"PHASE1":2932,"PHASE2":2934,"PHASE3":2936,"PHASE4":2942,"NA":2944},{"trials":2931,"activeCount":100},[],{"trials":2933,"activeCount":100},[],{"trials":2935,"activeCount":100},[],{"trials":2937,"activeCount":100},[2938],{"nctId":1314,"briefTitle":1315,"status":298,"phases":2939,"completion":1317,"start":1318,"enrollment":154,"conditions":2940,"interventions":2941},[91],[1320],[1322,1323],{"trials":2943,"activeCount":100},[],{"trials":2945,"activeCount":100},[2946],{"nctId":2947,"briefTitle":2948,"status":298,"phases":2949,"primaryCompletion":1367,"completion":1367,"start":1147,"enrollment":154,"conditions":2950,"interventions":2953},"NCT01623921","Statins and Selective Cyclooxygenase-2 Receptor Inhibitors in Blunt Chest Trauma",[93],[2951,2952],"Blunt Chest Trauma","Acute Respiratory Distress Syndrome",[2954,2955,2956,2957],"standard care treatment","Celecoxib","Rosuvastatin","Combined therapy",{"intervention":2959,"totalTrials":96,"cells":2960},"Cannabis oil",{"EARLY_PHASE1":2961,"PHASE1":2963,"PHASE2":2965,"PHASE3":2967,"PHASE4":2969,"NA":2971},{"trials":2962,"activeCount":100},[],{"trials":2964,"activeCount":100},[],{"trials":2966,"activeCount":100},[],{"trials":2968,"activeCount":100},[],{"trials":2970,"activeCount":100},[],{"trials":2972,"activeCount":100},[2973],{"nctId":2974,"briefTitle":2975,"status":298,"phases":2976,"primaryCompletion":1587,"completion":1587,"start":2977,"enrollment":8,"conditions":2978,"interventions":2979},"NCT02560545","Cannabinoids Effects on the Pain Modulation System",[93],"2015-09",[2530],[2959],{"intervention":2981,"totalTrials":96,"cells":2982},"normal saline 3 ml, morphine 3mg",{"EARLY_PHASE1":2983,"PHASE1":2985,"PHASE2":2987,"PHASE3":2989,"PHASE4":2991,"NA":2993},{"trials":2984,"activeCount":100},[],{"trials":2986,"activeCount":100},[],{"trials":2988,"activeCount":100},[],{"trials":2990,"activeCount":100},[],{"trials":2992,"activeCount":100},[],{"trials":2994,"activeCount":100},[2995],{"nctId":2996,"briefTitle":2997,"status":396,"phases":2998,"completion":2999,"start":3000,"enrollment":8,"conditions":3001,"interventions":3002},"NCT01095575","Pre- Versus Post-Incisional Epidural Morphine: Higher Postoperative Pain Perception and Extra Morphine Consumption",[93],"2008-01","2006-01",[15],[2981],{"intervention":3004,"totalTrials":96,"cells":3005},"a combination of PCA MO and continuous infusion of MO",{"EARLY_PHASE1":3006,"PHASE1":3008,"PHASE2":3010,"PHASE3":3012,"PHASE4":3014,"NA":3016},{"trials":3007,"activeCount":100},[],{"trials":3009,"activeCount":100},[],{"trials":3011,"activeCount":100},[],{"trials":3013,"activeCount":100},[],{"trials":3015,"activeCount":100},[],{"trials":3017,"activeCount":100},[3018],{"nctId":3019,"briefTitle":3020,"status":298,"phases":3021,"primaryCompletion":1098,"completion":2058,"start":2888,"enrollment":2279,"conditions":3022,"interventions":3023},"NCT00849719","Effects of a Combination of IV-PCA With Continuous IV Infusion of MO, Versus IV-PCA MO on Postoperative Pain",[93],[402],[3004,3024],"PCA MO only",{"intervention":3024,"totalTrials":96,"cells":3026},{"EARLY_PHASE1":3027,"PHASE1":3029,"PHASE2":3031,"PHASE3":3033,"PHASE4":3035,"NA":3037},{"trials":3028,"activeCount":100},[],{"trials":3030,"activeCount":100},[],{"trials":3032,"activeCount":100},[],{"trials":3034,"activeCount":100},[],{"trials":3036,"activeCount":100},[],{"trials":3038,"activeCount":100},[3039],{"nctId":3019,"briefTitle":3020,"status":298,"phases":3040,"primaryCompletion":1098,"completion":2058,"start":2888,"enrollment":2279,"conditions":3041,"interventions":3042},[93],[402],[3004,3024],{"intervention":3044,"totalTrials":96,"cells":3045},"Inactivated split virion Influenza vaccine",{"EARLY_PHASE1":3046,"PHASE1":3048,"PHASE2":3050,"PHASE3":3052,"PHASE4":3054,"NA":3056},{"trials":3047,"activeCount":100},[],{"trials":3049,"activeCount":100},[],{"trials":3051,"activeCount":100},[],{"trials":3053,"activeCount":100},[],{"trials":3055,"activeCount":100},[],{"trials":3057,"activeCount":100},[3058],{"nctId":3059,"briefTitle":3060,"status":298,"phases":3061,"primaryCompletion":2085,"completion":3062,"start":3063,"enrollment":539,"conditions":3064,"interventions":3066},"NCT01465477","Influenza Vaccination in Fibromyalgia Patients",[93],"2012-11","2011-11",[3065],"Fibromyalgia Syndrome",[3044,3067],"WHO recommended 2011 Influenza vacccine",{"intervention":3067,"totalTrials":96,"cells":3069},{"EARLY_PHASE1":3070,"PHASE1":3072,"PHASE2":3074,"PHASE3":3076,"PHASE4":3078,"NA":3080},{"trials":3071,"activeCount":100},[],{"trials":3073,"activeCount":100},[],{"trials":3075,"activeCount":100},[],{"trials":3077,"activeCount":100},[],{"trials":3079,"activeCount":100},[],{"trials":3081,"activeCount":100},[3082],{"nctId":3059,"briefTitle":3060,"status":298,"phases":3083,"primaryCompletion":2085,"completion":3062,"start":3063,"enrollment":539,"conditions":3084,"interventions":3085},[93],[3065],[3044,3067],{"intervention":3087,"totalTrials":96,"cells":3088},"Tetra Hydro Cannabinol",{"EARLY_PHASE1":3089,"PHASE1":3091,"PHASE2":3093,"PHASE3":3095,"PHASE4":3097,"NA":3099},{"trials":3090,"activeCount":100},[],{"trials":3092,"activeCount":100},[],{"trials":3094,"activeCount":100},[],{"trials":3096,"activeCount":100},[],{"trials":3098,"activeCount":100},[],{"trials":3100,"activeCount":100},[3101],{"nctId":3102,"briefTitle":3103,"status":396,"phases":3104,"primaryCompletion":3105,"completion":3105,"start":1872,"enrollment":333,"conditions":3106,"interventions":3107},"NCT00270803","The Effects of Marijuana on Orientation and Motor Coordination and Brain Metabolism in Regular Smokers of Marijuana",[93],"2005-12",[2689],[3087],{"intervention":3109,"totalTrials":96,"cells":3110},"Dehydroepiandrosterone",{"EARLY_PHASE1":3111,"PHASE1":3113,"PHASE2":3115,"PHASE3":3117,"PHASE4":3119,"NA":3121},{"trials":3112,"activeCount":100},[],{"trials":3114,"activeCount":100},[],{"trials":3116,"activeCount":100},[],{"trials":3118,"activeCount":100},[],{"trials":3120,"activeCount":100},[],{"trials":3122,"activeCount":100},[3123],{"nctId":3124,"briefTitle":3125,"status":298,"phases":3126,"primaryCompletion":317,"completion":372,"start":1307,"enrollment":114,"conditions":3127,"interventions":3129},"NCT00916396","Dehydroepiandrosterone (DHEA) Treatment in Women and Men Experiencing Hypoactive Sexual Desire Disorder",[93],[3128],"Hypoactive Sexual Desire Disorder",[3109],{"intervention":3131,"totalTrials":96,"cells":3132},"paracetamol",{"EARLY_PHASE1":3133,"PHASE1":3135,"PHASE2":3137,"PHASE3":3139,"PHASE4":3141,"NA":3143},{"trials":3134,"activeCount":100},[],{"trials":3136,"activeCount":100},[],{"trials":3138,"activeCount":100},[],{"trials":3140,"activeCount":100},[],{"trials":3142,"activeCount":100},[],{"trials":3144,"activeCount":100},[3145],{"nctId":3146,"briefTitle":3147,"status":298,"phases":3148,"primaryCompletion":1075,"start":1097,"enrollment":229,"conditions":3149,"interventions":3150},"NCT01073748","The Effect of Single Dose Paracetamol on the Lower Airways of Asthmatic and Healthy Children",[93],[34],[3131],{"intervention":3152,"totalTrials":96,"cells":3153},"oral ketamine",{"EARLY_PHASE1":3154,"PHASE1":3156,"PHASE2":3158,"PHASE3":3160,"PHASE4":3162,"NA":3164},{"trials":3155,"activeCount":100},[],{"trials":3157,"activeCount":100},[],{"trials":3159,"activeCount":100},[],{"trials":3161,"activeCount":100},[],{"trials":3163,"activeCount":100},[],{"trials":3165,"activeCount":100},[3166],{"nctId":3167,"briefTitle":3168,"status":298,"phases":3169,"primaryCompletion":2210,"completion":2210,"start":3170,"enrollment":114,"conditions":3171,"interventions":3174},"NCT01207206","Oral Ketamine as an Adjuvant to Opioids for Pain Treatment in Cancer Patients",[93],"2010-10",[3172,15,3173],"Cancer","Tolerance",[3152],{"intervention":3176,"totalTrials":96,"cells":3177},"Levodopa",{"EARLY_PHASE1":3178,"PHASE1":3180,"PHASE2":3182,"PHASE3":3184,"PHASE4":3186,"NA":3188},{"trials":3179,"activeCount":100},[],{"trials":3181,"activeCount":100},[],{"trials":3183,"activeCount":100},[],{"trials":3185,"activeCount":100},[],{"trials":3187,"activeCount":100},[],{"trials":3189,"activeCount":100},[3190],{"nctId":3191,"briefTitle":3192,"status":298,"phases":3193,"primaryCompletion":1682,"start":301,"enrollment":208,"conditions":3194,"interventions":3196},"NCT01937169","Targeting Dopamine Therapy in RLS",[93],[3195],"Restless Legs Syndrome",[3176],{"intervention":3198,"totalTrials":96,"cells":3199},"Montelukast",{"EARLY_PHASE1":3200,"PHASE1":3202,"PHASE2":3204,"PHASE3":3206,"PHASE4":3208,"NA":3210},{"trials":3201,"activeCount":100},[],{"trials":3203,"activeCount":100},[],{"trials":3205,"activeCount":100},[],{"trials":3207,"activeCount":100},[],{"trials":3209,"activeCount":100},[],{"trials":3211,"activeCount":100},[3212],{"nctId":3213,"briefTitle":3214,"status":298,"phases":3215,"primaryCompletion":909,"completion":1271,"start":680,"enrollment":3216,"conditions":3217,"interventions":3220},"NCT01967498","Montelukast for Children With Chronic Otitis Media With Effusion (COME): A Double-blind, Placebo-controlled Study",[93],52,[3218,3219],"Chronic Otitis Media With Effusion","Conductive Hearing Loss",[3198],{"intervention":3222,"totalTrials":96,"cells":3223},"Simvastatine",{"EARLY_PHASE1":3224,"PHASE1":3226,"PHASE2":3228,"PHASE3":3230,"PHASE4":3232,"NA":3234},{"trials":3225,"activeCount":100},[],{"trials":3227,"activeCount":100},[],{"trials":3229,"activeCount":100},[],{"trials":3231,"activeCount":100},[],{"trials":3233,"activeCount":100},[],{"trials":3235,"activeCount":100},[3236],{"nctId":3237,"briefTitle":3238,"status":298,"phases":3239,"primaryCompletion":2302,"start":524,"enrollment":19,"conditions":3240,"interventions":3242},"NCT01382511","Simvastatin Treatment of Pachyonychia Congenita",[93],[3241],"Pachyonychia Congenita",[3222],{"intervention":3244,"totalTrials":96,"cells":3245},"Methadone",{"EARLY_PHASE1":3246,"PHASE1":3248,"PHASE2":3250,"PHASE3":3252,"PHASE4":3254,"NA":3256},{"trials":3247,"activeCount":100},[],{"trials":3249,"activeCount":100},[],{"trials":3251,"activeCount":100},[],{"trials":3253,"activeCount":100},[],{"trials":3255,"activeCount":100},[],{"trials":3257,"activeCount":100},[3258],{"nctId":3259,"briefTitle":3260,"status":298,"phases":3261,"primaryCompletion":3262,"completion":372,"start":2695,"enrollment":154,"conditions":3263,"interventions":3265},"NCT00999440","QTc and Perceived Sleep Follow up Among Chronic Pain Patients With Opiate Medication",[93],"2010-12",[3264],"Chronic Pain",[3244],{"intervention":3267,"totalTrials":96,"cells":3268},"Betamethasone acetate + Betamethasone sodium phosphate",{"EARLY_PHASE1":3269,"PHASE1":3271,"PHASE2":3273,"PHASE3":3275,"PHASE4":3277,"NA":3279},{"trials":3270,"activeCount":100},[],{"trials":3272,"activeCount":100},[],{"trials":3274,"activeCount":100},[],{"trials":3276,"activeCount":100},[],{"trials":3278,"activeCount":100},[],{"trials":3280,"activeCount":100},[3281],{"nctId":3282,"briefTitle":3283,"status":298,"phases":3284,"primaryCompletion":3285,"completion":3285,"start":3286,"enrollment":8,"conditions":3287,"interventions":3292},"NCT04593706","Comparison of the Efficacy of Different Steroids in the Treatment of Abnormal Scars (Keloids, Hypertrophic Scars)",[93],"2021-10-31","2020-11-01",[3288,3289,3290,3291],"Keloid","Hypertrophic Scar","Scars","Scarring",[3267,3293,3294,3295],"Dexamethasone sodium phosphate","Methylprednisolone acetate","Triamcinolone acetonide",{"intervention":3293,"totalTrials":96,"cells":3297},{"EARLY_PHASE1":3298,"PHASE1":3300,"PHASE2":3302,"PHASE3":3304,"PHASE4":3306,"NA":3308},{"trials":3299,"activeCount":100},[],{"trials":3301,"activeCount":100},[],{"trials":3303,"activeCount":100},[],{"trials":3305,"activeCount":100},[],{"trials":3307,"activeCount":100},[],{"trials":3309,"activeCount":100},[3310],{"nctId":3282,"briefTitle":3283,"status":298,"phases":3311,"primaryCompletion":3285,"completion":3285,"start":3286,"enrollment":8,"conditions":3312,"interventions":3313},[93],[3288,3289,3290,3291],[3267,3293,3294,3295],{"intervention":3294,"totalTrials":96,"cells":3315},{"EARLY_PHASE1":3316,"PHASE1":3318,"PHASE2":3320,"PHASE3":3322,"PHASE4":3324,"NA":3326},{"trials":3317,"activeCount":100},[],{"trials":3319,"activeCount":100},[],{"trials":3321,"activeCount":100},[],{"trials":3323,"activeCount":100},[],{"trials":3325,"activeCount":100},[],{"trials":3327,"activeCount":100},[3328],{"nctId":3282,"briefTitle":3283,"status":298,"phases":3329,"primaryCompletion":3285,"completion":3285,"start":3286,"enrollment":8,"conditions":3330,"interventions":3331},[93],[3288,3289,3290,3291],[3267,3293,3294,3295],{"intervention":3295,"totalTrials":96,"cells":3333},{"EARLY_PHASE1":3334,"PHASE1":3336,"PHASE2":3338,"PHASE3":3340,"PHASE4":3342,"NA":3344},{"trials":3335,"activeCount":100},[],{"trials":3337,"activeCount":100},[],{"trials":3339,"activeCount":100},[],{"trials":3341,"activeCount":100},[],{"trials":3343,"activeCount":100},[],{"trials":3345,"activeCount":100},[3346],{"nctId":3282,"briefTitle":3283,"status":298,"phases":3347,"primaryCompletion":3285,"completion":3285,"start":3286,"enrollment":8,"conditions":3348,"interventions":3349},[93],[3288,3289,3290,3291],[3267,3293,3294,3295],{"intervention":3351,"totalTrials":96,"cells":3352},"Loteprendol etabonate 0.5%",{"EARLY_PHASE1":3353,"PHASE1":3355,"PHASE2":3357,"PHASE3":3359,"PHASE4":3361,"NA":3363},{"trials":3354,"activeCount":100},[],{"trials":3356,"activeCount":100},[],{"trials":3358,"activeCount":100},[],{"trials":3360,"activeCount":100},[],{"trials":3362,"activeCount":100},[],{"trials":3364,"activeCount":100},[3365],{"nctId":3366,"briefTitle":3367,"status":298,"phases":3368,"primaryCompletion":3369,"completion":3369,"start":910,"enrollment":154,"conditions":3370,"interventions":3372},"NCT02825186","Dexamethasone (Sterodex) Versus Loteprendol (Lotemax) Eye Drops Following Strabismus Surgery",[93],"2018-06",[3371],"Ophthalmology",[3351,3373],"Dexamethasone 0.1%",{"intervention":3373,"totalTrials":96,"cells":3375},{"EARLY_PHASE1":3376,"PHASE1":3378,"PHASE2":3380,"PHASE3":3382,"PHASE4":3384,"NA":3386},{"trials":3377,"activeCount":100},[],{"trials":3379,"activeCount":100},[],{"trials":3381,"activeCount":100},[],{"trials":3383,"activeCount":100},[],{"trials":3385,"activeCount":100},[],{"trials":3387,"activeCount":100},[3388],{"nctId":3366,"briefTitle":3367,"status":298,"phases":3389,"primaryCompletion":3369,"completion":3369,"start":910,"enrollment":154,"conditions":3390,"interventions":3391},[93],[3371],[3351,3373],{"intervention":3393,"totalTrials":96,"cells":3394},"fecal transplant",{"EARLY_PHASE1":3395,"PHASE1":3397,"PHASE2":3399,"PHASE3":3401,"PHASE4":3403,"NA":3405},{"trials":3396,"activeCount":100},[],{"trials":3398,"activeCount":100},[],{"trials":3400,"activeCount":100},[],{"trials":3402,"activeCount":100},[],{"trials":3404,"activeCount":100},[],{"trials":3406,"activeCount":100},[3407],{"nctId":3408,"briefTitle":3409,"status":298,"phases":3410,"primaryCompletion":1846,"completion":3411,"start":3412,"enrollment":757,"conditions":3413,"interventions":3415},"NCT04833179","Fecal Transplant for Alopecia Areata",[93],"2025-04","2021-05",[3414],"Alopecia Areata",[3393],{"intervention":3417,"totalTrials":96,"cells":3418},"IV acetaminophen",{"EARLY_PHASE1":3419,"PHASE1":3421,"PHASE2":3423,"PHASE3":3425,"PHASE4":3427,"NA":3429},{"trials":3420,"activeCount":100},[],{"trials":3422,"activeCount":100},[],{"trials":3424,"activeCount":100},[],{"trials":3426,"activeCount":100},[],{"trials":3428,"activeCount":100},[],{"trials":3430,"activeCount":100},[3431],{"nctId":3432,"briefTitle":3433,"status":396,"phases":3434,"primaryCompletion":3435,"completion":3435,"start":3436,"enrollment":154,"conditions":3437,"interventions":3439},"NCT04933058","Opioid Based Analgesia vs Non-opioid Analgesia for Oocyte Retrieval Procedure",[93],"2022-10-30","2021-12-05",[3438],"Women Undergoing Oocyte Retrieval Procedures",[3417,3440],"IV fentanyl",{"intervention":3440,"totalTrials":96,"cells":3442},{"EARLY_PHASE1":3443,"PHASE1":3445,"PHASE2":3447,"PHASE3":3449,"PHASE4":3451,"NA":3453},{"trials":3444,"activeCount":100},[],{"trials":3446,"activeCount":100},[],{"trials":3448,"activeCount":100},[],{"trials":3450,"activeCount":100},[],{"trials":3452,"activeCount":100},[],{"trials":3454,"activeCount":100},[3455],{"nctId":3432,"briefTitle":3433,"status":396,"phases":3456,"primaryCompletion":3435,"completion":3435,"start":3436,"enrollment":154,"conditions":3457,"interventions":3458},[93],[3438],[3417,3440],{"intervention":3460,"totalTrials":96,"cells":3461},"Moxifloxacin",{"EARLY_PHASE1":3462,"PHASE1":3464,"PHASE2":3466,"PHASE3":3468,"PHASE4":3470,"NA":3472},{"trials":3463,"activeCount":100},[],{"trials":3465,"activeCount":100},[],{"trials":3467,"activeCount":100},[],{"trials":3469,"activeCount":100},[],{"trials":3471,"activeCount":100},[],{"trials":3473,"activeCount":100},[3474],{"nctId":3475,"briefTitle":3476,"status":396,"phases":3477,"primaryCompletion":3478,"completion":653,"start":3479,"enrollment":3480,"conditions":3481,"interventions":3483},"NCT02680080","Effect of Grapefruit on QT Interval in Healthy Volunteers and Patients With Congenital Long QT Syndrome",[93],"2018-06-12","2016-12-01",25,[3482],"Long QT Syndrome",[3460],{"intervention":3485,"totalTrials":96,"cells":3486},"5-Aminolevulinic Acid-Containing Product in Cutaneous Dose Form",{"EARLY_PHASE1":3487,"PHASE1":3489,"PHASE2":3491,"PHASE3":3493,"PHASE4":3495,"NA":3497},{"trials":3488,"activeCount":100},[],{"trials":3490,"activeCount":100},[],{"trials":3492,"activeCount":100},[],{"trials":3494,"activeCount":100},[],{"trials":3496,"activeCount":100},[],{"trials":3498,"activeCount":100},[3499],{"nctId":3500,"briefTitle":3501,"status":396,"phases":3502,"primaryCompletion":3503,"completion":3503,"start":3504,"enrollment":1224,"conditions":3505,"interventions":3506},"NCT04631250","Conventional Photodynamic Therapy Versus Daylight Photodynamic Therapy for The Treatment of Acne Vulgaris",[93],"2020-07-01","2018-11-01",[2013],[3485],{"intervention":321,"totalTrials":96,"cells":3508},{"EARLY_PHASE1":3509,"PHASE1":3511,"PHASE2":3513,"PHASE3":3515,"PHASE4":3517,"NA":3519},{"trials":3510,"activeCount":100},[],{"trials":3512,"activeCount":100},[],{"trials":3514,"activeCount":100},[],{"trials":3516,"activeCount":100},[],{"trials":3518,"activeCount":100},[],{"trials":3520,"activeCount":100},[3521],{"nctId":313,"briefTitle":314,"status":298,"phases":3522,"primaryCompletion":316,"completion":316,"start":317,"enrollment":154,"conditions":3523,"interventions":3524},[93],[319],[321,322],{"intervention":3526,"totalTrials":96,"cells":3527},"Low Dose Fentanyl",{"EARLY_PHASE1":3528,"PHASE1":3530,"PHASE2":3532,"PHASE3":3534,"PHASE4":3536,"NA":3538},{"trials":3529,"activeCount":100},[],{"trials":3531,"activeCount":100},[],{"trials":3533,"activeCount":100},[],{"trials":3535,"activeCount":100},[],{"trials":3537,"activeCount":100},[],{"trials":3539,"activeCount":100},[3540],{"nctId":3541,"briefTitle":3542,"status":298,"phases":3543,"primaryCompletion":3544,"completion":3544,"start":3545,"enrollment":3546,"conditions":3547,"interventions":3550},"NCT04202887","The Effect of Low-Dose vs High-Dose Epidural Fentanyl on Gastric Emptying - A Prospective Double-Blinded Randomized Controlled Trial",[93],"2020-10-30","2020-07-30",81,[3548,3549],"Effects of; Anesthesia, Spinal and Epidural, in Pregnancy","Aspiration",[3526,3551],"High Dose Fentanyl",{"intervention":3551,"totalTrials":96,"cells":3553},{"EARLY_PHASE1":3554,"PHASE1":3556,"PHASE2":3558,"PHASE3":3560,"PHASE4":3562,"NA":3564},{"trials":3555,"activeCount":100},[],{"trials":3557,"activeCount":100},[],{"trials":3559,"activeCount":100},[],{"trials":3561,"activeCount":100},[],{"trials":3563,"activeCount":100},[],{"trials":3565,"activeCount":100},[3566],{"nctId":3541,"briefTitle":3542,"status":298,"phases":3567,"primaryCompletion":3544,"completion":3544,"start":3545,"enrollment":3546,"conditions":3568,"interventions":3569},[93],[3548,3549],[3526,3551],{"intervention":404,"totalTrials":96,"cells":3571},{"EARLY_PHASE1":3572,"PHASE1":3574,"PHASE2":3576,"PHASE3":3578,"PHASE4":3580,"NA":3582},{"trials":3573,"activeCount":100},[],{"trials":3575,"activeCount":100},[],{"trials":3577,"activeCount":100},[],{"trials":3579,"activeCount":100},[],{"trials":3581,"activeCount":100},[],{"trials":3583,"activeCount":100},[3584],{"nctId":394,"briefTitle":395,"status":396,"phases":3585,"primaryCompletion":398,"completion":398,"start":399,"enrollment":400,"conditions":3586,"interventions":3587},[93],[402],[380,404],{"intervention":3589,"totalTrials":96,"cells":3590},"sevelamer hydrochloride",{"EARLY_PHASE1":3591,"PHASE1":3593,"PHASE2":3595,"PHASE3":3597,"PHASE4":3599,"NA":3601},{"trials":3592,"activeCount":100},[],{"trials":3594,"activeCount":100},[],{"trials":3596,"activeCount":100},[],{"trials":3598,"activeCount":100},[],{"trials":3600,"activeCount":100},[],{"trials":3602,"activeCount":100},[3603],{"nctId":3604,"briefTitle":3605,"status":396,"phases":3606,"primaryCompletion":954,"completion":954,"start":3607,"enrollment":3608,"conditions":3609,"interventions":3613},"NCT01049815","Sevelamer Hydrochloride and Femoral and Carotid Intima Media Thickness Progression in End Stage Renal Disease",[93],"2005-02",175,[3610,3611,3612],"End Stage Renal Disease","Hemodialysis","Intimal Media Thickness",[3589,3614],"Calcium Carbonate",{"intervention":3614,"totalTrials":96,"cells":3616},{"EARLY_PHASE1":3617,"PHASE1":3619,"PHASE2":3621,"PHASE3":3623,"PHASE4":3625,"NA":3627},{"trials":3618,"activeCount":100},[],{"trials":3620,"activeCount":100},[],{"trials":3622,"activeCount":100},[],{"trials":3624,"activeCount":100},[],{"trials":3626,"activeCount":100},[],{"trials":3628,"activeCount":100},[3629],{"nctId":3604,"briefTitle":3605,"status":396,"phases":3630,"primaryCompletion":954,"completion":954,"start":3607,"enrollment":3608,"conditions":3631,"interventions":3632},[93],[3610,3611,3612],[3589,3614],{"intervention":3634,"totalTrials":96,"cells":3635},"Epinephrin",{"EARLY_PHASE1":3636,"PHASE1":3638,"PHASE2":3640,"PHASE3":3642,"PHASE4":3644,"NA":3646},{"trials":3637,"activeCount":100},[],{"trials":3639,"activeCount":100},[],{"trials":3641,"activeCount":100},[],{"trials":3643,"activeCount":100},[],{"trials":3645,"activeCount":100},[],{"trials":3647,"activeCount":100},[3648],{"nctId":3649,"briefTitle":3650,"status":298,"phases":3651,"primaryCompletion":2187,"completion":587,"start":1098,"enrollment":114,"conditions":3652,"interventions":3658},"NCT01075581","Intranasal Injection Versus Topical Administration of Epinephrin During Endoscopic Sinus Surgery",[93],[3653,3654,3655,3656,3657],"Hypertension","Hypotension","Tachycardia","Bradycardia","Arrhythmia",[3634,3634],{"intervention":3660,"totalTrials":96,"cells":3661},"Yohimbine",{"EARLY_PHASE1":3662,"PHASE1":3664,"PHASE2":3666,"PHASE3":3668,"PHASE4":3670,"NA":3672},{"trials":3663,"activeCount":100},[],{"trials":3665,"activeCount":100},[],{"trials":3667,"activeCount":100},[],{"trials":3669,"activeCount":100},[],{"trials":3671,"activeCount":100},[],{"trials":3673,"activeCount":100},[3674],{"nctId":3675,"briefTitle":3676,"status":298,"phases":3677,"primaryCompletion":1367,"completion":3678,"start":1147,"enrollment":1797,"conditions":3679,"interventions":3680},"NCT01621620","The Role of Sympatho-vagal Balance on Different Limbs of Pain Perception in Healthy Subjects",[93],"2014-08",[15],[3660],{"intervention":3682,"totalTrials":96,"cells":3683},"furosemide",{"EARLY_PHASE1":3684,"PHASE1":3686,"PHASE2":3688,"PHASE3":3690,"PHASE4":3692,"NA":3694},{"trials":3685,"activeCount":100},[],{"trials":3687,"activeCount":100},[],{"trials":3689,"activeCount":100},[],{"trials":3691,"activeCount":100},[],{"trials":3693,"activeCount":100},[],{"trials":3695,"activeCount":100},[3696],{"nctId":3697,"briefTitle":3698,"status":1121,"phases":3699,"primaryCompletion":2057,"completion":2057,"start":2210,"enrollment":100,"conditions":3700,"interventions":3702},"NCT01705470","Furosemide Treatment Before Blood Transfusion in Patients With Systolic Dysfunction",[93],[3701],"Anemia Treatment Among Patients Suffering From Left Ventricular Systolic Dysfunction",[3682],{"intervention":3704,"totalTrials":96,"cells":3705},"Colchicine",{"EARLY_PHASE1":3706,"PHASE1":3708,"PHASE2":3710,"PHASE3":3712,"PHASE4":3714,"NA":3716},{"trials":3707,"activeCount":100},[],{"trials":3709,"activeCount":100},[],{"trials":3711,"activeCount":100},[],{"trials":3713,"activeCount":100},[],{"trials":3715,"activeCount":100},[],{"trials":3717,"activeCount":100},[3718],{"nctId":3719,"briefTitle":3720,"status":1121,"phases":3721,"primaryCompletion":1682,"completion":1682,"start":1988,"enrollment":100,"conditions":3722,"interventions":3724},"NCT02095522","COlchicine Improve EnDothElial Function in Non ST Elevation Myocardial Infarction Patients",[93],[3723],"NSTEMI",[3704],{"intervention":3726,"totalTrials":96,"cells":3727},"Oxytocin",{"EARLY_PHASE1":3728,"PHASE1":3730,"PHASE2":3732,"PHASE3":3734,"PHASE4":3736,"NA":3738},{"trials":3729,"activeCount":100},[],{"trials":3731,"activeCount":100},[],{"trials":3733,"activeCount":100},[],{"trials":3735,"activeCount":100},[],{"trials":3737,"activeCount":100},[],{"trials":3739,"activeCount":100},[3740],{"nctId":3741,"briefTitle":3742,"status":298,"phases":3743,"primaryCompletion":3744,"start":3745,"enrollment":114,"conditions":3746,"interventions":3748},"NCT02191423","Oxytocin and Dyadic Psychotherapy in the Treatment of Post Partum Depression",[93],"2016-06","2015-01",[3747],"Postpartum Depression",[3726],{"intervention":3750,"totalTrials":96,"cells":3751},"Sci-B-Vac",{"EARLY_PHASE1":3752,"PHASE1":3754,"PHASE2":3756,"PHASE3":3758,"PHASE4":3760,"NA":3762},{"trials":3753,"activeCount":100},[],{"trials":3755,"activeCount":100},[],{"trials":3757,"activeCount":100},[],{"trials":3759,"activeCount":100},[],{"trials":3761,"activeCount":100},[],{"trials":3763,"activeCount":100},[3764],{"nctId":3765,"briefTitle":3766,"status":298,"phases":3767,"primaryCompletion":3768,"completion":680,"start":3063,"enrollment":154,"conditions":3769,"interventions":3771},"NCT01437475","Efficiency of the Hepatitis B Sci-B-Vac Vaccine in HIV Positive Patients",[93],"2013-03",[3770],"HIV",[3750],{"intervention":3773,"totalTrials":96,"cells":3774},"Local application pentostam",{"EARLY_PHASE1":3775,"PHASE1":3777,"PHASE2":3779,"PHASE3":3781,"PHASE4":3783,"NA":3785},{"trials":3776,"activeCount":100},[],{"trials":3778,"activeCount":100},[],{"trials":3780,"activeCount":100},[],{"trials":3782,"activeCount":100},[],{"trials":3784,"activeCount":100},[],{"trials":3786,"activeCount":100},[3787],{"nctId":3788,"briefTitle":3789,"status":298,"phases":3790,"primaryCompletion":1965,"completion":754,"start":3791,"enrollment":1797,"conditions":3792,"interventions":3794},"NCT03009422","Fractional CO2 Laser With Topical Pentostam Treatment for Cutaneous Leishmaniasis.",[93],"2014-11",[3793],"Leishmaniasis",[3773,3795],"intra-lisional pentostam",{"intervention":3795,"totalTrials":96,"cells":3797},{"EARLY_PHASE1":3798,"PHASE1":3800,"PHASE2":3802,"PHASE3":3804,"PHASE4":3806,"NA":3808},{"trials":3799,"activeCount":100},[],{"trials":3801,"activeCount":100},[],{"trials":3803,"activeCount":100},[],{"trials":3805,"activeCount":100},[],{"trials":3807,"activeCount":100},[],{"trials":3809,"activeCount":100},[3810],{"nctId":3788,"briefTitle":3789,"status":298,"phases":3811,"primaryCompletion":1965,"completion":754,"start":3791,"enrollment":1797,"conditions":3812,"interventions":3813},[93],[3793],[3773,3795],{"intervention":3815,"totalTrials":96,"cells":3816},"aminophylline",{"EARLY_PHASE1":3817,"PHASE1":3819,"PHASE2":3821,"PHASE3":3823,"PHASE4":3825,"NA":3827},{"trials":3818,"activeCount":100},[],{"trials":3820,"activeCount":100},[],{"trials":3822,"activeCount":100},[],{"trials":3824,"activeCount":100},[],{"trials":3826,"activeCount":100},[],{"trials":3828,"activeCount":100},[3829],{"nctId":3830,"briefTitle":3831,"status":298,"phases":3832,"conditions":3833,"interventions":3835},"NCT01280071","Adenosine Activity in Producing Venoarteriolar Reflexes",[93],[3834],"Venoarteriolar Reflex",[3815],{"intervention":3837,"totalTrials":96,"cells":3838},"Sevoflurane",{"EARLY_PHASE1":3839,"PHASE1":3841,"PHASE2":3843,"PHASE3":3845,"PHASE4":3847,"NA":3849},{"trials":3840,"activeCount":100},[],{"trials":3842,"activeCount":100},[],{"trials":3844,"activeCount":100},[],{"trials":3846,"activeCount":100},[],{"trials":3848,"activeCount":100},[],{"trials":3850,"activeCount":100},[3851],{"nctId":3852,"briefTitle":3853,"status":298,"phases":3854,"primaryCompletion":3855,"start":3856,"enrollment":208,"conditions":3857,"interventions":3859},"NCT01575626","The Effect of Different Sevoflurane Concentrations on Intraocular Pressure in Patients Undergoing Ocular Surgery Under General Anesthesia",[93],"2013-05","2012-05",[3858],"IOP Changes Due to Anesthesia (Healthy Patients)",[3837],{"intervention":3861,"totalTrials":96,"cells":3862},"Grazoprevir\u002FElbasvir",{"EARLY_PHASE1":3863,"PHASE1":3865,"PHASE2":3867,"PHASE3":3869,"PHASE4":3871,"NA":3873},{"trials":3864,"activeCount":100},[],{"trials":3866,"activeCount":100},[],{"trials":3868,"activeCount":100},[],{"trials":3870,"activeCount":100},[],{"trials":3872,"activeCount":100},[],{"trials":3874,"activeCount":100},[3875],{"nctId":3876,"briefTitle":3877,"status":298,"phases":3878,"primaryCompletion":3879,"completion":3880,"start":3881,"enrollment":1797,"conditions":3882,"interventions":3884},"NCT03110055","the Effect of Grazoprevir\u002FElbasvir and TACE vs. TACE Alone in Prolonging Survival of Patients With Non-resectable HCV Associated HCC.",[93],"2018-05-01","2019-05-01","2017-05-01",[3883],"HCV, HCC",[3861],{"intervention":3886,"totalTrials":96,"cells":3887},"liberal fluid administration",{"EARLY_PHASE1":3888,"PHASE1":3890,"PHASE2":3892,"PHASE3":3894,"PHASE4":3896,"NA":3898},{"trials":3889,"activeCount":100},[],{"trials":3891,"activeCount":100},[],{"trials":3893,"activeCount":100},[],{"trials":3895,"activeCount":100},[],{"trials":3897,"activeCount":100},[],{"trials":3899,"activeCount":100},[3900],{"nctId":3901,"briefTitle":3902,"status":298,"phases":3903,"primaryCompletion":3904,"completion":3905,"start":3906,"enrollment":375,"conditions":3907,"interventions":3911},"NCT00854386","Effect of Intraoperative Fluid Restriction on Postoperative Outcomes in Video-assisted Thoracic Surgery (VATS)",[93],"2011-05","2011-09","2009-05",[3908,3909,3910],"Acute Lung Injury (ALI)","Acure Respiratory Distress Syndrome (ARDS)","Sepsis",[3886,3912],"restrictive fluid administration",{"intervention":3912,"totalTrials":96,"cells":3914},{"EARLY_PHASE1":3915,"PHASE1":3917,"PHASE2":3919,"PHASE3":3921,"PHASE4":3923,"NA":3925},{"trials":3916,"activeCount":100},[],{"trials":3918,"activeCount":100},[],{"trials":3920,"activeCount":100},[],{"trials":3922,"activeCount":100},[],{"trials":3924,"activeCount":100},[],{"trials":3926,"activeCount":100},[3927],{"nctId":3901,"briefTitle":3902,"status":298,"phases":3928,"primaryCompletion":3904,"completion":3905,"start":3906,"enrollment":375,"conditions":3929,"interventions":3930},[93],[3908,3909,3910],[3886,3912],{"intervention":3932,"totalTrials":96,"cells":3933},"Rivastigmine",{"EARLY_PHASE1":3934,"PHASE1":3936,"PHASE2":3938,"PHASE3":3940,"PHASE4":3942,"NA":3944},{"trials":3935,"activeCount":100},[],{"trials":3937,"activeCount":100},[],{"trials":3939,"activeCount":100},[],{"trials":3941,"activeCount":100},[],{"trials":3943,"activeCount":100},[],{"trials":3945,"activeCount":100},[3946],{"nctId":3947,"briefTitle":3948,"status":396,"phases":3949,"primaryCompletion":2888,"completion":2888,"start":2600,"enrollment":1224,"conditions":3950,"interventions":3952},"NCT00624663","A Double-Blind, Placebo-controlled Crossover Study of Repeat Rivastigmine Administration in Healthy Male Volunteers",[93],[3951],"Rivastigmine Toxicity",[3932],{"intervention":3954,"totalTrials":96,"cells":3955},"Lactated Ringer's solution",{"EARLY_PHASE1":3956,"PHASE1":3958,"PHASE2":3960,"PHASE3":3962,"PHASE4":3964,"NA":3966},{"trials":3957,"activeCount":100},[],{"trials":3959,"activeCount":100},[],{"trials":3961,"activeCount":100},[],{"trials":3963,"activeCount":100},[],{"trials":3965,"activeCount":100},[],{"trials":3967,"activeCount":100},[3968],{"nctId":3969,"briefTitle":3970,"status":396,"phases":3971,"primaryCompletion":3972,"completion":3972,"start":3973,"enrollment":3974,"conditions":3975,"interventions":3982},"NCT00905502","Intraoperative Fluid Management in Laparoscopic Bariatric Surgery",[93],"2008-12","2007-04",107,[3976,3977,3978,3979,3980,3981],"Morbid Obesity","Acidosis","Intra-Abdominal Abscess","Hemorrhage","Reflux","Vomiting",[3954,3954],{"intervention":2658,"totalTrials":96,"cells":3984},{"EARLY_PHASE1":3985,"PHASE1":3987,"PHASE2":3989,"PHASE3":3991,"PHASE4":3993,"NA":3995},{"trials":3986,"activeCount":100},[],{"trials":3988,"activeCount":100},[],{"trials":3990,"activeCount":100},[],{"trials":3992,"activeCount":100},[],{"trials":3994,"activeCount":100},[],{"trials":3996,"activeCount":100},[3997],{"nctId":2652,"briefTitle":2653,"status":298,"phases":3998,"primaryCompletion":373,"completion":373,"start":317,"enrollment":2279,"conditions":3999,"interventions":4000},[93],[2656],[2658,2606],{"intervention":4002,"totalTrials":96,"cells":4003},"Bacteriotherapy",{"EARLY_PHASE1":4004,"PHASE1":4006,"PHASE2":4008,"PHASE3":4010,"PHASE4":4012,"NA":4014},{"trials":4005,"activeCount":100},[],{"trials":4007,"activeCount":100},[],{"trials":4009,"activeCount":100},[],{"trials":4011,"activeCount":100},[],{"trials":4013,"activeCount":100},[],{"trials":4015,"activeCount":100},[4016],{"nctId":4017,"briefTitle":4018,"status":298,"phases":4019,"primaryCompletion":4020,"completion":4021,"start":4022,"enrollment":4023,"conditions":4024,"interventions":4027},"NCT03218579","Endoscopic Assessment and Prediction of Microbiome-modifying Interventions",[93],"2019-12-30","2020-12-30","2013-02-01",45,[4025,4026],"Gut Microbiome","Antibiotic Side Effect",[4002],{"intervention":4029,"totalTrials":96,"cells":4030},"Hepatitis B vaccination",{"EARLY_PHASE1":4031,"PHASE1":4033,"PHASE2":4035,"PHASE3":4037,"PHASE4":4039,"NA":4041},{"trials":4032,"activeCount":100},[],{"trials":4034,"activeCount":100},[],{"trials":4036,"activeCount":100},[],{"trials":4038,"activeCount":100},[],{"trials":4040,"activeCount":100},[],{"trials":4042,"activeCount":100},[4043],{"nctId":4044,"briefTitle":4045,"status":396,"phases":4046,"primaryCompletion":4047,"completion":4047,"start":4048,"enrollment":4049,"conditions":4050,"interventions":4052},"NCT03951870","Characterization of the Relationship Between the Human Mesolimbic Reward System and Immune Functioning",[93],"2022-08-28","2019-01-20",85,[4051],"Immune Hepatitis",[4029],{"intervention":4054,"totalTrials":96,"cells":4055},"Bupropion",{"EARLY_PHASE1":4056,"PHASE1":4058,"PHASE2":4060,"PHASE3":4062,"PHASE4":4064,"NA":4066},{"trials":4057,"activeCount":100},[],{"trials":4059,"activeCount":100},[],{"trials":4061,"activeCount":100},[],{"trials":4063,"activeCount":100},[],{"trials":4065,"activeCount":100},[],{"trials":4067,"activeCount":100},[4068],{"nctId":4069,"briefTitle":4070,"status":396,"phases":4071,"primaryCompletion":4072,"completion":4072,"start":1872,"enrollment":4073,"conditions":4074,"interventions":4076},"NCT00267813","The Effects of Craving and Abstinence From Cigarettes on Brain Metabolism in Smokers",[93],"2007-10",24,[4075],"Nicotine Dependence",[4054],{"intervention":4078,"totalTrials":96,"cells":4079},"Vitamin D",{"EARLY_PHASE1":4080,"PHASE1":4082,"PHASE2":4084,"PHASE3":4086,"PHASE4":4088,"NA":4090},{"trials":4081,"activeCount":100},[],{"trials":4083,"activeCount":100},[],{"trials":4085,"activeCount":100},[],{"trials":4087,"activeCount":100},[],{"trials":4089,"activeCount":100},[],{"trials":4091,"activeCount":100},[4092],{"nctId":4093,"briefTitle":4094,"status":396,"phases":4095,"primaryCompletion":2210,"completion":2210,"start":2695,"enrollment":333,"conditions":4096,"interventions":4099},"NCT01023490","Vitamin D Treatment to Patients Suffering From Chronic Pain and Vitamin D Hypovitaminosis",[93],[4097,4098],"Back Pain","Hypovitaminosis D",[4078],{"intervention":4101,"totalTrials":96,"cells":4102},"Medical Cannabis",{"EARLY_PHASE1":4103,"PHASE1":4105,"PHASE2":4107,"PHASE3":4109,"PHASE4":4111,"NA":4113},{"trials":4104,"activeCount":100},[],{"trials":4106,"activeCount":100},[],{"trials":4108,"activeCount":100},[],{"trials":4110,"activeCount":100},[],{"trials":4112,"activeCount":100},[],{"trials":4114,"activeCount":100},[4115],{"nctId":4116,"briefTitle":4117,"status":396,"phases":4118,"primaryCompletion":4119,"completion":4119,"start":3503,"enrollment":4120,"conditions":4121,"interventions":4124},"NCT05115318","The Effect of Medical Cannabis on Tics, Premonitory Urge and Psychiatric Comorbidity in Adults With Tourette Syndrome",[],"2021-03-31",18,[4122,4123],"Tourette Syndrome","Cannabis",[4101],{"intervention":4126,"totalTrials":96,"cells":4127},"Intrathecal morphine",{"EARLY_PHASE1":4128,"PHASE1":4130,"PHASE2":4132,"PHASE3":4134,"PHASE4":4136,"NA":4138},{"trials":4129,"activeCount":100},[],{"trials":4131,"activeCount":100},[],{"trials":4133,"activeCount":100},[],{"trials":4135,"activeCount":100},[],{"trials":4137,"activeCount":100},[],{"trials":4139,"activeCount":100},[4140],{"nctId":4141,"briefTitle":4142,"status":298,"phases":4143,"primaryCompletion":3063,"completion":316,"start":4144,"enrollment":1638,"conditions":4145,"interventions":4147},"NCT01201499","Comparing the Outcome of Two Intraoperative Analgesia Techniques After Hepato-pancreato-biliary Surgery",[93],"2010-11",[15,390,4146],"Sedation",[4126,4148],"Continuous IV remifentanil",{"intervention":4148,"totalTrials":96,"cells":4150},{"EARLY_PHASE1":4151,"PHASE1":4153,"PHASE2":4155,"PHASE3":4157,"PHASE4":4159,"NA":4161},{"trials":4152,"activeCount":100},[],{"trials":4154,"activeCount":100},[],{"trials":4156,"activeCount":100},[],{"trials":4158,"activeCount":100},[],{"trials":4160,"activeCount":100},[],{"trials":4162,"activeCount":100},[4163],{"nctId":4141,"briefTitle":4142,"status":298,"phases":4164,"primaryCompletion":3063,"completion":316,"start":4144,"enrollment":1638,"conditions":4165,"interventions":4166},[93],[15,390,4146],[4126,4148],{"intervention":4168,"totalTrials":96,"cells":4169},"Estradiol",{"EARLY_PHASE1":4170,"PHASE1":4172,"PHASE2":4174,"PHASE3":4176,"PHASE4":4178,"NA":4180},{"trials":4171,"activeCount":100},[],{"trials":4173,"activeCount":100},[],{"trials":4175,"activeCount":100},[],{"trials":4177,"activeCount":100},[],{"trials":4179,"activeCount":100},[],{"trials":4181,"activeCount":100},[4182],{"nctId":4183,"briefTitle":4184,"status":396,"phases":4185,"primaryCompletion":4186,"completion":4186,"start":4187,"enrollment":208,"conditions":4188,"interventions":4195},"NCT07145281","Comparing the Effects of Sublingual Estradiol Treatment Versus Oral Estradiol With Cyproterone Acetate (CPA) Treatment on The Coagulation System in Transgender Women: A Prospective, Controlled Cohort Study",[93],"2024-11-10","2022-11-10",[4189,4190,4191,4192,4193,4194],"Gender Dysphoria, Adult","Blood Coagulation","Coagulation Factors","Transgender Persons, M01.777.500","Hemostasis","Transgender Women",[4168,4196],"Cyproterone Acetate",{"intervention":4196,"totalTrials":96,"cells":4198},{"EARLY_PHASE1":4199,"PHASE1":4201,"PHASE2":4203,"PHASE3":4205,"PHASE4":4207,"NA":4209},{"trials":4200,"activeCount":100},[],{"trials":4202,"activeCount":100},[],{"trials":4204,"activeCount":100},[],{"trials":4206,"activeCount":100},[],{"trials":4208,"activeCount":100},[],{"trials":4210,"activeCount":100},[4211],{"nctId":4183,"briefTitle":4184,"status":396,"phases":4212,"primaryCompletion":4186,"completion":4186,"start":4187,"enrollment":208,"conditions":4213,"interventions":4214},[93],[4189,4190,4191,4192,4193,4194],[4168,4196],{"intervention":4216,"totalTrials":96,"cells":4217},"Probiotics",{"EARLY_PHASE1":4218,"PHASE1":4220,"PHASE2":4222,"PHASE3":4224,"PHASE4":4226,"NA":4228},{"trials":4219,"activeCount":100},[],{"trials":4221,"activeCount":100},[],{"trials":4223,"activeCount":100},[],{"trials":4225,"activeCount":100},[],{"trials":4227,"activeCount":100},[],{"trials":4229,"activeCount":100},[4230],{"nctId":4231,"briefTitle":4232,"status":2083,"phases":4233,"primaryCompletion":4234,"completion":4234,"start":4235,"enrollment":4236,"conditions":4237,"interventions":4239},"NCT00835874","Probiotic Administartion to Mothers of Preterm Infants to Prevent Necrotizing Enterocolitis and Sepsis",[93],"2009-07","2007-06",57,[4238,3910],"Necrotizing Enterocolitis",[4216],{"intervention":4241,"totalTrials":96,"cells":4242},"Naltrexone",{"EARLY_PHASE1":4243,"PHASE1":4245,"PHASE2":4247,"PHASE3":4249,"PHASE4":4251,"NA":4253},{"trials":4244,"activeCount":100},[],{"trials":4246,"activeCount":100},[],{"trials":4248,"activeCount":100},[],{"trials":4250,"activeCount":100},[],{"trials":4252,"activeCount":100},[],{"trials":4254,"activeCount":100},[4255],{"nctId":4256,"briefTitle":4257,"status":298,"phases":4258,"primaryCompletion":2779,"completion":2779,"start":2210,"enrollment":4073,"conditions":4259,"interventions":4261},"NCT01560013","The Effects of Treatment With Naltrexone in Alcohol and Cannabis-dependent Patients",[93],[4260],"Alcohol-dependence",[4241],{"intervention":4263,"totalTrials":96,"cells":4264},"Sertraline",{"EARLY_PHASE1":4265,"PHASE1":4267,"PHASE2":4269,"PHASE3":4271,"PHASE4":4273,"NA":4275},{"trials":4266,"activeCount":100},[],{"trials":4268,"activeCount":100},[],{"trials":4270,"activeCount":100},[],{"trials":4272,"activeCount":100},[],{"trials":4274,"activeCount":100},[],{"trials":4276,"activeCount":100},[4277],{"nctId":4278,"briefTitle":4279,"status":396,"phases":4280,"primaryCompletion":4144,"completion":317,"start":4281,"enrollment":4282,"conditions":4283,"interventions":4284},"NCT01028482","Treatment of Postpartum Depression With Psychotherapy and Add-on Sertraline",[93],"2008-03",42,[3747],[4263],{"intervention":4286,"totalTrials":96,"cells":4287},"saline nasal irrigation alone",{"EARLY_PHASE1":4288,"PHASE1":4290,"PHASE2":4292,"PHASE3":4294,"PHASE4":4296,"NA":4298},{"trials":4289,"activeCount":100},[],{"trials":4291,"activeCount":100},[],{"trials":4293,"activeCount":100},[],{"trials":4295,"activeCount":100},[],{"trials":4297,"activeCount":100},[],{"trials":4299,"activeCount":100},[4300],{"nctId":4301,"briefTitle":4302,"status":298,"phases":4303,"primaryCompletion":2057,"completion":4304,"start":2085,"enrollment":400,"conditions":4305,"interventions":4307},"NCT01582555","Postoperative Nasal Irrigation Using Mucolytic Agents",[93],"2013-12",[4306],"Surgical Procedure, Unspecified",[4286,4308],"dissolved N-Acetylcystine",{"intervention":4308,"totalTrials":96,"cells":4310},{"EARLY_PHASE1":4311,"PHASE1":4313,"PHASE2":4315,"PHASE3":4317,"PHASE4":4319,"NA":4321},{"trials":4312,"activeCount":100},[],{"trials":4314,"activeCount":100},[],{"trials":4316,"activeCount":100},[],{"trials":4318,"activeCount":100},[],{"trials":4320,"activeCount":100},[],{"trials":4322,"activeCount":100},[4323],{"nctId":4301,"briefTitle":4302,"status":298,"phases":4324,"primaryCompletion":2057,"completion":4304,"start":2085,"enrollment":400,"conditions":4325,"interventions":4326},[93],[4306],[4286,4308],{"intervention":2927,"totalTrials":96,"cells":4328},{"EARLY_PHASE1":4329,"PHASE1":4331,"PHASE2":4333,"PHASE3":4335,"PHASE4":4337,"NA":4339},{"trials":4330,"activeCount":100},[],{"trials":4332,"activeCount":100},[],{"trials":4334,"activeCount":100},[],{"trials":4336,"activeCount":100},[],{"trials":4338,"activeCount":100},[],{"trials":4340,"activeCount":100},[4341],{"nctId":2921,"briefTitle":2922,"status":298,"phases":4342,"primaryCompletion":2924,"completion":1437,"start":2779,"enrollment":19,"conditions":4343,"interventions":4344},[93],[15],[2532,2927],{"intervention":4346,"totalTrials":96,"cells":4347},"Oxybutynin",{"EARLY_PHASE1":4348,"PHASE1":4350,"PHASE2":4352,"PHASE3":4354,"PHASE4":4356,"NA":4358},{"trials":4349,"activeCount":100},[],{"trials":4351,"activeCount":100},[],{"trials":4353,"activeCount":100},[],{"trials":4355,"activeCount":100},[],{"trials":4357,"activeCount":100},[],{"trials":4359,"activeCount":100},[4360],{"nctId":4361,"briefTitle":4362,"status":396,"phases":4363,"primaryCompletion":1437,"completion":4364,"start":4365,"enrollment":181,"conditions":4366,"interventions":4368},"NCT02973659","The Use of Topical Oxybutynin 10% for Treating Primary Focal Hyperhidrosis-axillary, Palmar and Plantar.",[93],"2016-10","2015-05",[4367],"Hyperhidrosis",[4346,4369],"Placebos",{"intervention":4369,"totalTrials":96,"cells":4371},{"EARLY_PHASE1":4372,"PHASE1":4374,"PHASE2":4376,"PHASE3":4378,"PHASE4":4380,"NA":4382},{"trials":4373,"activeCount":100},[],{"trials":4375,"activeCount":100},[],{"trials":4377,"activeCount":100},[],{"trials":4379,"activeCount":100},[],{"trials":4381,"activeCount":100},[],{"trials":4383,"activeCount":100},[4384],{"nctId":4361,"briefTitle":4362,"status":396,"phases":4385,"primaryCompletion":1437,"completion":4364,"start":4365,"enrollment":181,"conditions":4386,"interventions":4387},[93],[4367],[4346,4369],{"intervention":4389,"totalTrials":96,"cells":4390},"Paracetamol 1000 mg",{"EARLY_PHASE1":4391,"PHASE1":4393,"PHASE2":4395,"PHASE3":4397,"PHASE4":4399,"NA":4401},{"trials":4392,"activeCount":100},[],{"trials":4394,"activeCount":100},[],{"trials":4396,"activeCount":100},[],{"trials":4398,"activeCount":100},[],{"trials":4400,"activeCount":100},[],{"trials":4402,"activeCount":100},[4403],{"nctId":4404,"briefTitle":4405,"status":396,"phases":4406,"primaryCompletion":4407,"completion":4408,"start":4409,"enrollment":3974,"conditions":4410,"interventions":4411},"NCT04653506","Paracetamol \u002F Ibuprofen for Postpartum Pain in the Early Postpartum Period",[93],"2022-07-01","2023-07-06","2020-11-28",[15],[4389,4412],"Ibuprofen 400 mg",{"intervention":4412,"totalTrials":96,"cells":4414},{"EARLY_PHASE1":4415,"PHASE1":4417,"PHASE2":4419,"PHASE3":4421,"PHASE4":4423,"NA":4425},{"trials":4416,"activeCount":100},[],{"trials":4418,"activeCount":100},[],{"trials":4420,"activeCount":100},[],{"trials":4422,"activeCount":100},[],{"trials":4424,"activeCount":100},[],{"trials":4426,"activeCount":100},[4427],{"nctId":4404,"briefTitle":4405,"status":396,"phases":4428,"primaryCompletion":4407,"completion":4408,"start":4409,"enrollment":3974,"conditions":4429,"interventions":4430},[93],[15],[4389,4412],{"intervention":4432,"totalTrials":96,"cells":4433},"Etodalac, Etoricoxib and Dexamethasone",{"EARLY_PHASE1":4434,"PHASE1":4436,"PHASE2":4438,"PHASE3":4440,"PHASE4":4442,"NA":4444},{"trials":4435,"activeCount":100},[],{"trials":4437,"activeCount":100},[],{"trials":4439,"activeCount":100},[],{"trials":4441,"activeCount":100},[],{"trials":4443,"activeCount":100},[],{"trials":4445,"activeCount":100},[4446],{"nctId":4447,"briefTitle":4448,"status":298,"phases":4449,"primaryCompletion":953,"completion":953,"start":563,"enrollment":539,"conditions":4450,"interventions":4453},"NCT00793052","Etodalac, Etoricoxib and Dexamethasone for Prevention of Pain ,Swelling and Trismus Following Third Molar Surgery",[93],[4451,4452,15],"Trismus","Edema",[4432],{"intervention":2954,"totalTrials":96,"cells":4455},{"EARLY_PHASE1":4456,"PHASE1":4458,"PHASE2":4460,"PHASE3":4462,"PHASE4":4464,"NA":4466},{"trials":4457,"activeCount":100},[],{"trials":4459,"activeCount":100},[],{"trials":4461,"activeCount":100},[],{"trials":4463,"activeCount":100},[],{"trials":4465,"activeCount":100},[],{"trials":4467,"activeCount":100},[4468],{"nctId":2947,"briefTitle":2948,"status":298,"phases":4469,"primaryCompletion":1367,"completion":1367,"start":1147,"enrollment":154,"conditions":4470,"interventions":4471},[93],[2951,2952],[2954,2955,2956,2957],{"intervention":2956,"totalTrials":96,"cells":4473},{"EARLY_PHASE1":4474,"PHASE1":4476,"PHASE2":4478,"PHASE3":4480,"PHASE4":4482,"NA":4484},{"trials":4475,"activeCount":100},[],{"trials":4477,"activeCount":100},[],{"trials":4479,"activeCount":100},[],{"trials":4481,"activeCount":100},[],{"trials":4483,"activeCount":100},[],{"trials":4485,"activeCount":100},[4486],{"nctId":2947,"briefTitle":2948,"status":298,"phases":4487,"primaryCompletion":1367,"completion":1367,"start":1147,"enrollment":154,"conditions":4488,"interventions":4489},[93],[2951,2952],[2954,2955,2956,2957],{"intervention":2957,"totalTrials":96,"cells":4491},{"EARLY_PHASE1":4492,"PHASE1":4494,"PHASE2":4496,"PHASE3":4498,"PHASE4":4500,"NA":4502},{"trials":4493,"activeCount":100},[],{"trials":4495,"activeCount":100},[],{"trials":4497,"activeCount":100},[],{"trials":4499,"activeCount":100},[],{"trials":4501,"activeCount":100},[],{"trials":4503,"activeCount":100},[4504],{"nctId":2947,"briefTitle":2948,"status":298,"phases":4505,"primaryCompletion":1367,"completion":1367,"start":1147,"enrollment":154,"conditions":4506,"interventions":4507},[93],[2951,2952],[2954,2955,2956,2957]]